Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Dec. 31, 2023 | Jan. 26, 2024 | |
Cover [Abstract] | ||
Entity Registrant Name | EXTREME NETWORKS, INC. | |
Entity Central Index Key | 0001078271 | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Shell Company | false | |
Entity Emerging Growth Company | false | |
Document Type | 10-Q | |
Document Period End Date | Dec. 31, 2023 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Trading Symbol | EXTR | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 128,730,411 | |
Entity File Number | 000-25711 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 77-0430270 | |
Entity Address, Address Line One | 2121 RDU Center Drive, Suite 300 | |
Entity Address, City or Town | Morrisville | |
Entity Address, State or Province | NC | |
Entity Address, Postal Zip Code | 27560 | |
City Area Code | 408 | |
Local Phone Number | 579-2800 | |
Title of 12(b) Security | Common Stock | |
Security Exchange Name | NASDAQ | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Interactive Data Current | Yes | |
Entity Current Reporting Status | Yes |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 221,403 | $ 234,826 |
Accounts receivable, net | 112,047 | 182,045 |
Inventories | 152,521 | 89,024 |
Prepaid expenses and other current assets | 72,272 | 70,263 |
Total current assets | 558,243 | 576,158 |
Property and equipment, net | 47,598 | 46,448 |
Operating lease right-of-use assets, net | 47,124 | 34,739 |
Intangible assets, net | 13,104 | 16,063 |
Goodwill | 395,606 | 394,755 |
Other assets | 80,983 | 73,544 |
Total assets | 1,142,658 | 1,141,707 |
Current liabilities: | ||
Current portion of long-term debt, net of unamortized debt issuance costs of $675 and $674, respectively | 9,325 | 34,326 |
Accounts payable | 87,790 | 99,724 |
Accrued compensation and benefits | 50,862 | 71,367 |
Accrued warranty | 11,397 | 12,322 |
Current portion of operating lease liabilities | 10,686 | 10,847 |
Current portion of deferred revenue | 300,399 | 282,475 |
Other accrued liabilities | 78,507 | 64,440 |
Total current liabilities | 548,966 | 575,501 |
Deferred revenue, less current portion | 247,777 | 219,024 |
Long-term debt, less current portion, net of unamortized debt issuance costs of $2,069 and $2,409, respectively | 182,931 | 187,591 |
Operating lease liabilities, less current portion | 43,852 | 31,845 |
Deferred income taxes | 7,748 | 7,747 |
Other long-term liabilities | 3,200 | 3,247 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity: | ||
Convertible preferred stock, $0.001 par value, issuable in series, 2,000 shares authorized; none issued | ||
Common stock, $0.001 par value, 750,000 shares authorized; 146,843 and 143,629 shares issued, respectively; 128,624 and 127,775 shares outstanding, respectively | 147 | 144 |
Additional paid-in-capital | 1,181,230 | 1,173,744 |
Accumulated other comprehensive loss | (12,058) | (13,192) |
Accumulated deficit | (823,334) | (855,998) |
Treasury stock at cost, 18,219 and 15,854 shares, respectively | (237,801) | (187,946) |
Total stockholders’ equity | 108,184 | 116,752 |
Total liabilities and stockholders’ equity | $ 1,142,658 | $ 1,141,707 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Current liabilities: | ||
Net of unamortized debt issuance costs | $ 675 | $ 674 |
Noncurrent liabilities: | ||
Net of unamortized debt issuance costs | $ 2,069 | $ 2,409 |
Stockholders’ equity: | ||
Convertible preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Convertible preferred stock, shares authorized | 2,000,000 | 2,000,000 |
Convertible preferred stock, shares issued | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 750,000,000 | 750,000,000 |
Common stock, shares issued | 146,843,000 | 143,629,000 |
Common stock, shares outstanding | 128,624,000 | 127,775,000 |
Treasury Stock, Shares | 18,219,000 | 15,854,000 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Net revenues: | ||||
Total net revenues | $ 296,377 | $ 318,348 | $ 649,514 | $ 616,037 |
Cost of revenues: | ||||
Total cost of revenues | 113,007 | 136,693 | 253,208 | 267,674 |
Gross profit: | ||||
Total gross profit | 183,370 | 181,655 | 396,306 | 348,363 |
Operating expenses: | ||||
Research and development | 52,833 | 52,618 | 110,849 | 103,607 |
Sales and marketing | 85,154 | 80,538 | 177,074 | 158,920 |
General and administrative | 25,384 | 24,085 | 49,257 | 42,632 |
Acquisition and integration costs | 390 | |||
Restructuring and related charges | 9,174 | 476 | 11,891 | 957 |
Amortization of intangible assets | 509 | 504 | 1,020 | 1,027 |
Total operating expenses | 173,054 | 158,221 | 350,091 | 307,533 |
Operating income | 10,316 | 23,434 | 46,215 | 40,830 |
Interest income | 1,430 | 889 | 2,656 | 1,281 |
Interest expense | (4,269) | (3,884) | (8,587) | (7,710) |
Other income (expense), net | (420) | 138 | 12 | 509 |
Income before income taxes | 7,057 | 20,577 | 40,296 | 34,910 |
Provision for income taxes | 3,069 | 2,646 | 7,632 | 4,394 |
Net income | $ 3,988 | $ 17,931 | $ 32,664 | $ 30,516 |
Basic and diluted income per share: | ||||
Net income per share – basic | $ 0.03 | $ 0.14 | $ 0.25 | $ 0.23 |
Net income per share – diluted | $ 0.03 | $ 0.13 | $ 0.25 | $ 0.23 |
Shares used in per share calculation – basic | 128,987 | 130,465 | 128,885 | 130,377 |
Shares used in per share calculation – diluted | 131,514 | 134,453 | 132,786 | 133,833 |
Product | ||||
Net revenues: | ||||
Total net revenues | $ 186,611 | $ 223,445 | $ 440,094 | $ 429,721 |
Cost of revenues: | ||||
Total cost of revenues | 81,493 | 103,587 | 190,029 | 203,350 |
Gross profit: | ||||
Total gross profit | 105,118 | 119,858 | 250,065 | 226,371 |
Subscription and Support | ||||
Net revenues: | ||||
Total net revenues | 109,766 | 94,903 | 209,420 | 186,316 |
Cost of revenues: | ||||
Total cost of revenues | 31,514 | 33,106 | 63,179 | 64,324 |
Gross profit: | ||||
Total gross profit | $ 78,252 | $ 61,797 | $ 146,241 | $ 121,992 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 3,988 | $ 17,931 | $ 32,664 | $ 30,516 |
Derivatives designated as hedging instruments: | ||||
Change in unrealized gains and losses on interest rate swaps | 29 | 328 | ||
Reclassification adjustment related to interest rate swaps | (558) | (834) | ||
Change in unrealized gains and losses on foreign currency forward contracts | 358 | 358 | ||
Net change from derivatives designated as hedging instruments | (171) | (148) | ||
Net change in foreign currency translation adjustments | 4,038 | (8,205) | 1,134 | (10,343) |
Other comprehensive income (loss): | 4,038 | (8,376) | 1,134 | (10,491) |
Total comprehensive income | $ 8,026 | $ 9,555 | $ 33,798 | $ 20,025 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-In-Capital | Accumulated Other Comprehensive Loss | Treasury Stock | Accumulated Deficit |
Balance at Jun. 30, 2022 | $ 90,343 | $ 140 | $ 1,115,416 | $ (3,055) | $ (88,086) | $ (934,072) |
Balance, common stock, shares at Jun. 30, 2022 | 139,742 | (10,479) | ||||
Net income | 30,516 | 30,516 | ||||
Other comprehensive income (loss) | (10,491) | (10,491) | ||||
Issuance of common stock from equity incentive plans, net of tax withholdings | (7,183) | $ 2 | (7,185) | |||
Issuance of common stock from equity incentive plans, net of tax withholdings, shares | 2,395 | |||||
Repurchase of stock | (49,803) | $ (49,803) | ||||
Repurchase of stock, shares | (2,578) | |||||
Share-based compensation | 31,185 | 31,185 | ||||
Balance at Dec. 31, 2022 | 84,567 | $ 142 | 1,139,416 | (13,546) | $ (137,889) | (903,556) |
Balance, common stock, shares at Dec. 31, 2022 | 142,137 | (13,057) | ||||
Balance at Sep. 30, 2022 | 110,603 | $ 142 | 1,125,204 | (5,170) | $ (88,086) | (921,487) |
Balance, common stock, shares at Sep. 30, 2022 | 141,706 | (10,479) | ||||
Net income | 17,931 | 17,931 | ||||
Other comprehensive income (loss) | (8,376) | (8,376) | ||||
Issuance of common stock from equity incentive plans, net of tax withholdings | (3,184) | (3,184) | ||||
Issuance of common stock from equity incentive plans, net of tax withholdings, shares | 431 | |||||
Repurchase of stock | (49,803) | $ (49,803) | ||||
Repurchase of stock, shares | (2,578) | |||||
Share-based compensation | 17,396 | 17,396 | ||||
Balance at Dec. 31, 2022 | 84,567 | $ 142 | 1,139,416 | (13,546) | $ (137,889) | (903,556) |
Balance, common stock, shares at Dec. 31, 2022 | 142,137 | (13,057) | ||||
Balance at Jun. 30, 2023 | $ 116,752 | $ 144 | 1,173,744 | (13,192) | $ (187,946) | (855,998) |
Balance, common stock, shares at Jun. 30, 2023 | 143,629 | 143,629 | (15,854) | |||
Net income | $ 32,664 | 32,664 | ||||
Other comprehensive income (loss) | 1,134 | 1,134 | ||||
Issuance of common stock from equity incentive plans, net of tax withholdings | (33,387) | $ 3 | (33,390) | |||
Issuance of common stock from equity incentive plans, net of tax withholdings, shares | 3,214 | |||||
Repurchase of stock | (49,855) | $ (49,855) | ||||
Repurchase of stock, shares | (2,365) | |||||
Share-based compensation | 40,876 | 40,876 | ||||
Balance at Dec. 31, 2023 | $ 108,184 | $ 147 | 1,181,230 | (12,058) | $ (237,801) | (823,334) |
Balance, common stock, shares at Dec. 31, 2023 | 146,843 | 146,843 | (18,219) | |||
Balance at Sep. 30, 2023 | $ 108,482 | $ 146 | 1,164,589 | (16,096) | $ (212,835) | (827,322) |
Balance, common stock, shares at Sep. 30, 2023 | 146,264 | (16,734) | ||||
Net income | 3,988 | 3,988 | ||||
Other comprehensive income (loss) | 4,038 | 4,038 | ||||
Issuance of common stock from equity incentive plans, net of tax withholdings | (4,315) | $ 1 | (4,316) | |||
Issuance of common stock from equity incentive plans, net of tax withholdings, shares | 579 | |||||
Repurchase of stock | (24,966) | $ (24,966) | ||||
Repurchase of stock, shares | (1,485) | |||||
Share-based compensation | 20,957 | 20,957 | ||||
Balance at Dec. 31, 2023 | $ 108,184 | $ 147 | $ 1,181,230 | $ (12,058) | $ (237,801) | $ (823,334) |
Balance, common stock, shares at Dec. 31, 2023 | 146,843 | 146,843 | (18,219) |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 32,664 | $ 30,516 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation | 9,485 | 9,983 |
Amortization of intangible assets | 3,064 | 7,852 |
Reduction in carrying amount of right-of-use asset | 5,891 | 6,240 |
Provision for doubtful accounts | 82 | 102 |
Share-based compensation | 40,876 | 31,185 |
Deferred income taxes | (21) | 65 |
Non-cash interest expense | 532 | 764 |
Other | (2,481) | (5,904) |
Changes in operating assets and liabilities: | ||
Accounts receivable | 69,915 | 31,944 |
Inventories | (64,552) | (14,506) |
Prepaid expenses and other assets | (7,850) | (6,557) |
Accounts payable | (12,263) | 2,164 |
Accrued compensation and benefits | (20,625) | 9,170 |
Operating lease liabilities | (6,444) | (7,383) |
Deferred revenue | 48,272 | 28,776 |
Other current and long-term liabilities | 13,320 | (4,074) |
Net cash provided by operating activities | 109,865 | 120,337 |
Cash flows from investing activities: | ||
Capital expenditures | (9,955) | (6,271) |
Net cash used in investing activities | (9,955) | (6,271) |
Cash flows from financing activities: | ||
Payments on revolving facility | (25,000) | |
Payments on debt obligations | (5,000) | (46,625) |
Repurchase of common stock | (49,855) | (49,803) |
Payments for tax withholdings, net of proceeds from issuance of common stock | (33,387) | (7,183) |
Deferred payments on an acquisition | (2,000) | |
Net cash used in financing activities | (113,242) | (105,611) |
Foreign currency effect on cash and cash equivalents | (91) | (456) |
Net increase (decrease) in cash and cash equivalents | (13,423) | 7,999 |
Cash and cash equivalents at beginning of period | 234,826 | 194,522 |
Cash and cash equivalents at end of period | $ 221,403 | $ 202,521 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Pay vs Performance Disclosure | ||||
Net Income (Loss) | $ 3,988 | $ 17,931 | $ 32,664 | $ 30,516 |
Insider Trading Arrangements
Insider Trading Arrangements | 6 Months Ended |
Dec. 31, 2023 shares | |
Trading Arrangements, by Individual | |
Material Terms of Trading Arrangement | On November 6, 2023 , Ingrid J. Burton , a member of the Company's board of directors , terminated a Rule 10b5-1 trading arrangement that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and originally adopted on August 30, 2023 for the sale of up to 5,000 shares of the Company’s common stock until August 30, 2024. On December 8, 2023 , Joe Vitalone , the Company’s former Chief Revenue Officer terminated a Rule 10b5-1 trading arrangement that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and originally adopted on May 26, 2023 for the sale of up to 70,402 shares of the Company's common stock until July 31, 2024. |
Joe Vitalone | |
Trading Arrangements, by Individual | |
Name | Joe Vitalone |
Title | Company’s former Chief Revenue Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | May 26, 2023 |
Rule 10b5-1 Arrangement Terminated | true |
Termination Date | December 8, 2023 |
Aggregate Available | 70,402 |
Ingrid J. Burton | |
Trading Arrangements, by Individual | |
Name | Ingrid J. Burton |
Title | member of the Company's board of directors |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | August 30, 2023 |
Rule 10b5-1 Arrangement Terminated | true |
Termination Date | November 6, 2023 |
Aggregate Available | 5,000 |
Description of Business and Bas
Description of Business and Basis of Presentation | 6 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business and Basis of Presentation | 1. Description of Business and Basis of Presentation Extreme Networks, Inc., together with its subsidiaries (collectively referred to as “Extreme” or the “Company”), is a leader in providing software-driven networking solutions for enterprise customers. The Company conducts its sales and marketing activities on a worldwide basis through distributors, resellers, and the Company’s field sales organization. Extreme was incorporated in California in 1996 and reincorporated in Delaware in 1999. The unaudited condensed consolidated financial statements of Extreme included herein have been prepared under the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted under such rules and regulations. The condensed consolidated balance sheet at June 30, 2023 was derived from audited financial statements as of that date but does not include all disclosures required by generally accepted accounting principles for complete financial statements. These interim financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023. The unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments that, in the opinion of management, are necessary for a fair presentation of the results of operations and cash flows for the interim periods presented and the financial condition of Extreme at December 31, 2023. The results of operations for the three and six months ended December 31, 2023 are not necessarily indicative of the results that may be expected for fiscal 2024 or any future periods. Fiscal Year The Company uses a fiscal calendar year ending on June 30. All references herein to “fiscal 2024” represent the fiscal year ending June 30, 2024. All references herein to “fiscal 2023” represent the fiscal year ended June 30, 2023 . Principles of Consolidation The unaudited condensed consolidated financial statements include the accounts of Extreme and its wholly owned subsidiaries. All inter-company accounts and transactions have been eliminated. The Company predominantly uses the United States Dollar as its functional currency. The functional currency for certain of its foreign subsidiaries is the local currency. For those subsidiaries that operate in a local functional currency environment, all assets and liabilities are translated to United States Dollars at current month end rates of exchange and revenues, and expenses are translated using the monthly average rate. Accounting Estimates The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2. Summary of Significant Accounting Policies For a description of significant accounting policies, see Note 2, Summary of Significant Accounting Policies, to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023. There have been no material changes to the Company’s significant accounting policies since the filing of the Annual Report on Form 10-K. Recently Adopted Accounting Pronouncements There were no recently adopted accounting standards which would have a material effect on our condensed consolidated financial statements and accompanying disclosures. Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2023-07 on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures to enhance income tax disclosures primarily through changes in the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2023-09 on its consolidated financial statements and related disclosures . |
Revenues
Revenues | 6 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | 3. Revenues The Company accounts for revenues in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The Company derives the majority of its revenues from sales of its networking equipment, with the remaining revenues generated from sales of subscription and support, which primarily includes software subscriptions delivered as software as a service (“SaaS”) and additional revenues from maintenance contracts, professional services and training for its products. The Company sells its products, SaaS, and maintenance contracts direct to customers and to partners in two distribution channels, or tiers. The first tier consists of a limited number of independent distributors that stock the Company's products and sell primarily to resellers. The second tier of the distribution channel consists of non-stocking distributors and value-added resellers that sell directly to end-users. Products and subscription and support may be sold separately or in bundled packages. Revenue Recognition Performance Obligations. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Certain of the Company’s contracts have multiple performance obligations, as the promise to transfer individual goods or services is separately identifiable from other promises in the contracts and, therefore, is distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which the Company separately sells these products. For items that are not sold separately, the Company estimates the stand-alone selling prices using other observable inputs . The Company’s performance obligations are satisfied at a point in time or over time as the customer receives and consumes the benefits provided. Substantially all of the Company’s product sales revenues are recognized at a point in time. Substantially all of the Company’s subscription and support revenues are recognized over time. For revenues recognized over time, the Company uses an input measure, days elapsed, to measure progress. On December 31, 2023, the Company had $ 548.2 million of remaining performance obligations, which primarily comprised deferred maintenance and deferred SaaS revenues. The Company expects to recognize approximat ely 32 % of its deferred revenue as revenue in the remainder of fiscal 2024 , an additional 34 % in fiscal 2025, and 34 % of the balance thereafter . Contract Balances. The timing of revenue recognition, billings and cash collections results in billed accounts receivable and deferred revenue in the condensed consolidated balance sheets. Services provided under renewable support arrangements of the Company are billed in accordance with agreed-upon contractual terms, which are either billed fully at the inception of contract or at periodic intervals (e.g., quarterly or annually). The Company generally receives payments from its customers in advance of services being provided, resulting in deferred revenues. These liabilities are reported on the condensed consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. Revenue recognized for the three months ended December 31, 2023 and 2022 that was included in the deferred revenue balance at the beginning of each period w as $ 105.7 million and $ 83.9 million, respectively. Revenue recognized for the six months ended December 31, 2023 and 2022 that was included in the deferred revenue balance at the beginning of each period was $ 172.0 million and $ 145.7 million, respectively. Contract Costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Management expects that commission fees paid to sales representatives as a result of obtaining subscription and support contracts and contract renewals are recoverable and therefore the Company’s condensed consolidated balance sheets included capitalized balances in the amount of $ 22.2 million and $ 20.0 million at December 31, 2023 and June 30, 2023 , respectively. Capitalized commissions are included within other assets in the condensed consolidated balance sheets. Capitalized commission fees are amortized on a straight-line basis over the average period of service contracts of approximately three years , and are included in “Sales and marketing” in the accompanying condensed consolidated statements of operations. Amortization recognized during the three months ended December 31, 2023 and 2022 was $ 2.7 million and $ 2.2 million, respectively. Amortization recognized during the six months ended December 31, 2023 and 2022 was $ 5.2 million and $ 4.3 million, respectively. Estimated Variable Consideration. There were no material changes in the current period to the estimated variable consideration for performance obligations, which were satisfied or partially satisfied during previous periods. Revenues by Category The Company operates in three geographic regions: Americas, EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific). The following table sets forth the Company’s net revenues disaggregated by sales channel and geographic region based on the billing addresses of its customers (in thousands): Three Months Ended December 31, December 31, Distributor Direct Total Distributor Direct Total Americas: United States $ 81,350 $ 68,199 $ 149,549 $ 70,963 $ 66,630 $ 137,593 Other 8,244 4,842 13,086 10,807 4,614 15,421 Total Americas 89,594 73,041 162,635 81,770 71,244 153,014 EMEA 64,082 46,523 110,605 97,147 40,903 138,050 APAC 8,864 14,273 23,137 7,403 19,881 27,284 Total net revenues $ 162,540 $ 133,837 $ 296,377 $ 186,320 $ 132,028 $ 318,348 Six Months Ended December 31, December 31, Distributor Direct Total Distributor Direct Total Americas: United States $ 199,151 $ 133,150 $ 332,301 $ 144,277 $ 130,942 $ 275,219 Other 10,775 15,208 25,983 26,832 8,712 35,544 Total Americas 209,926 148,358 358,284 171,109 139,654 310,763 EMEA 166,393 87,815 254,208 173,403 80,156 253,559 APAC 8,975 28,047 37,022 9,441 42,274 51,715 Total net revenues $ 385,294 $ 264,220 $ 649,514 $ 353,953 $ 262,084 $ 616,037 For the three months ended December 31, 2023, the Company generated 10 % of its net revenues from Germany. For the six months ended December 31, 2023 , the Company generated approximately 11 % of its net revenues from the Netherlands. For the three months ended December 31, 2022, the Company generated 11 % and 10 % of its net revenues from the Netherlands and Germany, respectively. For the six months ended December 31, 2022, the Company generated 10 % of its net revenues from each of the Netherlands and Germany. No other foreign country accounted for 10 % or more of its net revenues for the three and six months ended December 31, 2023 and 2022 . Customer Concentrations The Company performs ongoing credit evaluations of its customers and generally does not require collateral in exchange for credit. The following table sets forth customers accounting for 10% or more of the Company’s net revenues for the periods indicated below: Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Jenne, Inc. 23 % 13 % 25 % 13 % Westcon Group, Inc. 10 % 19 % 18 % 17 % TD Synnex Corporation 24 % 17 % 21 % 18 % ScanSource, Inc. * 11 % * * * Less than 10% of revenue The following table sets forth major customers accounting for 10% or more of the Company’s net accounts receivable balance: December 31, June 30, Jenne, Inc. 52 % 39 % TD Synnex Corporation * 10 % ScanSource, Inc. * 10 % Ingram Micro 10 % * * Less than 10% of accounts receivable The Company's net accounts receivable balance with Jenne, Inc. as of December 31, 2023 is current and the Company expects to collect the majority of this balance by March 31, 2024. |
Balance Sheet Accounts
Balance Sheet Accounts | 6 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Balance Sheet Accounts | 4. Balance Sheet Accounts Cash and Cash Equivalents The Company considers highly liquid investments with maturities of three months or less at the date of purchase to be cash equivalents. The following table summarizes the Company's cash and cash equivalents (in thousands): December 31, June 30, Cash $ 211,526 $ 227,675 Cash equivalents 9,877 7,151 Total cash and cash equivalents $ 221,403 $ 234,826 Inventories Inventories are stated at the lower of cost, or net realizable value. Extreme uses a standard cost methodology to determine the cost basis for its inventories. Cost is computed using standard cost, which approximates actual cost, on a first-in, first-out basis. The Company adjusts the carrying value of its inventory when conditions exist that suggest that inventory may be in excess of anticipated demand or is obsolete based upon assumptions about future demand. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Any previously written down or obsolete inventory subsequently sold has not had a material impact on gross margin for any of the periods presented. The following table summarizes the Company's inventory by category (in thousands): December 31, June 30, Finished goods $ 124,668 $ 78,180 Raw materials 27,853 10,844 Total inventories $ 152,521 $ 89,024 Property and Equipment, Net The following table summarizes the Company's property and equipment, net by category (in thousands): December 31, June 30, Computers and equipment $ 83,633 $ 81,612 Purchased software 54,378 51,444 Office equipment, furniture and fixtures 9,002 8,899 Leasehold improvements 51,563 48,943 Total property and equipment 198,576 190,898 Less: accumulated depreciation and amortization ( 150,978 ) ( 144,450 ) Property and equipment, net $ 47,598 $ 46,448 Deferred Revenue Deferred revenue represents invoiced amounts for deferred maintenance, SaaS, and other deferred revenue including professional services and training when the revenue recognition criteria have not been met. Guarantees and Product Warranties The majority of the Company’s hardware products are shipped with either a one-year warranty or a limited lifetime warranty, and software products receive a 90 -day warranty. Upon shipment of products to its customers, the Company estimates expenses for the cost to repair or replace products that may be returned under warranty and accrues a liability in cost of product revenues for this amount. The determination of the Company’s warranty requirements is based on actual historical experience with the product or product family, estimates of repair and replacement costs, and any product warranty problems that are identified after shipment. The Company estimates and adjusts these accruals at each balance sheet date in accordance with changes in these factors. The following table summarizes the activity related to the Company’s product warranty liability during the following periods (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Balance beginning of period $ 12,164 $ 11,522 $ 12,322 $ 10,852 New warranties issued 2,777 3,807 6,451 7,815 Warranty expenditures ( 3,544 ) ( 3,509 ) ( 7,376 ) ( 6,847 ) Balance end of period $ 11,397 $ 11,820 $ 11,397 $ 11,820 To facilitate sales of its products in the normal course of business, the Company indemnifies its resellers and end-user customers with respect to certain matters. The Company has agreed to hold the customer harmless against losses arising from intellectual property infringement and certain other losses. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. It is not possible to estimate the maximum potential amount under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under these agreements have not had a material impact on its operating results or financial position. Concentrations The Company may be subject to concentration of credit risk as a result of certain financial instruments consisting of accounts receivable. See Note 3, Revenues, for the Company’s accounts receivable concentration. The Company does not invest an amount exceeding 10 % of its combined cash in the securities of any one obligor or maker, except for obligations of the United States government, obligations of United States government agencies, and money market accounts. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | 5. Fair Value Measurements A three-tier fair value hierarchy is utilized to prioritize the inputs used in measuring fair value. The hierarchy gives the highest priority to quoted prices in active markets (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels are defined as follows: • Level 1 Inputs - unadjusted quoted prices in active markets for identical assets or liabilities; • Level 2 Inputs - quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument; and • Level 3 Inputs - unobservable inputs reflecting the Company’s own assumptions in measuring the asset or liability at fair value. The following table presents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis at December 31, 2023 and June 30, 2023 (in thousands): December 31, 2023 Level 1 Level 2 Level 3 Total Assets Certificates of deposit $ — $ 9,877 $ — $ 9,877 Foreign currency derivatives — 133 — 133 Total assets measured at fair value $ — $ 10,010 $ — $ 10,010 June 30, 2023 Level 1 Level 2 Level 3 Total Assets Certificates of deposit $ — $ 7,151 $ — $ 7,151 Foreign currency derivatives — 31 — 31 Total assets measured at fair value $ — $ 7,182 $ — $ 7,182 Level 1 Assets and Liabilities: The Company’s financial instruments consist of cash, accounts receivable, accounts payable, and accrued liabilities. The Company states accounts receivable, accounts payable, and accrued liabilities at their carrying value, which approximates fair value due to the short time to the expected receipt or payment. Level 2 Assets and Liabilities: The Company's level 2 assets consist of certificates of deposit and derivative instruments. Certificates of deposit do not have regular market pricing and are considered Level 2. The fair value of derivative instruments under the Company’s foreign exchange forward contracts are estimated based on valuations provided by alternative pricing sources supported by observable inputs, which is considered Level 2. As of December 31, 2023 and June 30, 2023, the Company had investment in certificates of deposit of $ 9.9 million and $ 7.2 million, respectively, with maturity of three months at the date of purchase, which are recorded as cash equivalents in the condensed consolidated balance sheets. The Company considers these cash equivalents to be available-for-sale and, as of December 31, 2023 and June 30, 2023, their fair value approximated their amortized cost. As of December 31, 2023 and June 30, 2023, the Company had foreign exchange forward contracts that were not designated as hedging instruments with notional principal amounts of $ 15.6 million and $ 3.4 million, respectively. These contracts currently have maturities of 40 days or less. Changes in the fair value of these foreign exchange forward contracts not designated as hedging instruments are included in other income, net in the condensed consolidated statements of operations. For the three months ended December 31, 2023 and 2022, there were net gains of $ 0.4 million and $ 0.1 million , respectively. For the six months ended December 31, 2023 and 2022 , there were net gains of $ 0.3 million and net losses of $ 0.4 million, respectively. As of December 31, 2023 and June 30, 2023, there were no outstanding foreign exchange forward contracts that were designated as hedging instruments. See Note 12, Derivatives and Hedging, for additional information. The fair value of borrowings under the 2023 Credit Agreement (as defined in Note 7) is estimated based on valuations provided by alternative pricing sources supported by observable inputs which is considered Level 2. Since the interest rate is variable in the 2023 Credit Agreement, the fair value approximates the face amount of the Company’s indebtedness of $ 195.0 million and $ 225.0 million as of December 31, 2023 and June 30, 2023, respectively. Level 3 Assets and Liabilities: Certain of the Company’s assets, including intangible assets and goodwill, are measured at fair value on a non-recurring basis if impairment is indicated. As of December 31, 2023 and June 30, 2023 , the Company did no t have any assets or liabilities that were considered Level 3. There were no transfers of assets or liabilities between Level 1, Level 2, and Level 3 during the three and six months ended December 31, 2023 and 2022 . There were no impairments recorded for the three and six months ended December 31, 2023 and 2022 . |
Intangible Assets and Goodwill
Intangible Assets and Goodwill | 6 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets and Goodwill | 6. Intangible Assets and Goodwill Intangible Assets The following tables summarize the components of gross and net intangible assets (in thousands, except years): Weighted Average Remaining Amortization Gross Carrying Accumulated Net Carrying Period Amount Amortization Amount December 31, 2023 Developed technology 4.1 years $ 169,646 $ 161,690 $ 7,956 Customer relationships 2.9 years 64,721 59,787 4,934 Trade names 0 years 10,700 10,700 — License agreements 2.9 years 2,445 2,231 214 Total intangible assets, net* $ 247,512 $ 234,408 $ 13,104 * The carrying amount of foreign intangible assets are affected by foreign currency translation Weighted Average Remaining Amortization Gross Carrying Accumulated Net Carrying Period Amount Amortization Amount June 30, 2023 Developed technology 4.1 years $ 169,460 $ 159,592 $ 9,868 Customer relationships 3.4 years 64,839 58,894 5,945 Trade names 0 years 10,700 10,700 — License agreements 3.4 years 2,445 2,195 250 Total intangible assets, net* $ 247,444 $ 231,381 $ 16,063 * The carrying amount of foreign intangible assets are affected by foreign currency translation The following table summarizes the amortization expense of intangible assets for the periods presented (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Amortization of intangible assets in “Total cost of revenues” $ 611 $ 3,220 $ 2,044 $ 6,825 Amortization of intangible assets in “Total operating expenses” 509 504 1,020 1,027 Total amortization expense $ 1,120 $ 3,724 $ 3,064 $ 7,852 The amortization expense that is recognized in “Total cost of revenues” primarily consists of amortization related to developed technology and license agreements. The estimated future amortization expense to be recorded for each of the respective future fiscal years is as follows (in thousands): Amount For the fiscal year ending June 30: 2024 (the remainder of fiscal 2024) $ 2,585 2025 4,414 2026 3,165 2027 1,418 2028 1,259 Thereafter 263 Total $ 13,104 Goodwill The Company had Goodwill in the amount of $ 395.6 million and $ 394.8 million as of December 31, 2023 and June 30, 2023, respectively. The change in goodwill during the six months ended December 31, 2023 is due to foreign currency translation adjustment that is recorded as a component of accumulated other comprehensive loss. |
Debt
Debt | 6 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt | 7. Debt The Company’s debt is comprised of the following (in thousands): December 31, June 30, Current portion of long-term debt: Term Loan $ 10,000 $ 10,000 Revolving Facility — 25,000 Less: unamortized debt issuance costs ( 675 ) ( 674 ) Current portion of long-term debt $ 9,325 $ 34,326 Long-term debt, less current portion: Term Loan $ 185,000 $ 190,000 Less: unamortized debt issuance costs ( 2,069 ) ( 2,409 ) Total long-term debt, less current portion 182,931 187,591 Total debt $ 192,256 $ 221,917 On August 9, 2019, the Company entered into an Amended and Restated Credit Agreement (the “2019 Credit Agreement”), by and among the Company, as borrower, several banks and other financial institutions as Lenders, BMO Harris Bank N.A., as an issuing lender and swingline lender, Silicon Valley Bank, as an Issuing Lender, and Bank of Montreal, as administrative agent and collateral agent for the Lenders which was subsequently amended during fiscal 2023. On June 22, 2023, the Company entered into a Second Amended and Restated Credit Agreement (the “2023 Credit Agreement”), by and among the Company, as borrower, BMO Harris Bank, N.A., as an issuing lender and swingline lender, Bank of America, N.A., JPMorgan Chase Bank, N.A., PNC Bank, National Association, and Wells Fargo Bank, National Association, as issuing lenders, the financial institutions or entities party thereto as lenders, and Bank of Montreal, as administrative agent and collateral agent, which amended and restated the 2019 Credit Agreement. The 2023 Credit Agreement provides for i) a $ 200.0 million first lien term loan facility in an aggregate principal amount (the “2023 Term Loan”), ii) a $ 150.0 million five-year revolving credit facility (the “2023 Revolving Facility”) and, iii) an uncommitted additional incremental loan facility in the principal amount of up to $ 100.0 million. On June 22, 2023, the Company borrowed $ 25.0 million against its $ 150.0 million revolving credit facility to refinance its debt. On July 7, 2023, the Company made a payment of $ 25.0 million to pay off the outstanding revolving credit balance. Borrowings under the 2023 Credit Agreement bear interest, and at the Company’s election, the initial term loan may be made as either a base rate loan or a Secured Overnight Funding Rate (“SOFR”) loan. The applicable margin for base rate loans ranges from 1.00 % to 1.75 % per annum, and the applicable margin for SOFR loans ranges from 2.00 % to 2.75 %, in each case based on the Company’s consolidated leverage ratio. All SOFR loans are subject to a floor of 0.00 % per annum and spread adjustment of 0.10 % per annum. The Company paid other closing fees, arrangement fees, and administration fees associated with the 2023 Credit Agreement. The 2023 Credit Agreement requires the Company to maintain certain minimum financial ratios at the end of each fiscal quarter. The 2023 Credit Agreement also includes covenants and restrictions that limit, among other things, the Company’s ability to incur additional indebtedness, create liens upon any of its property, merge, consolidate or sell all or substantially all of its assets. The 2023 Credit Agreement also includes customary events of default which may result in acceleration of the outstanding balance. During the six months ended December 31, 2023, the Company was in compliance with all the terms and financial covenants of the 2023 Credit Agreement . Financing costs incurred in connection with obtaining long-term financing are deferred and amortized over the term of the related indebtedness or credit agreement. Amortization of deferred financing costs included in “Interest expense” in the accompanying condensed consolidated statements of operations were $ 0.3 million and $ 0.7 million for the three months ended December 31, 2023 and 2022 , respectively, and were $ 0.5 million and $ 1.5 million for the six months ended December 31, 2023 and 2022, respectively. The interest rate as of December 31, 2023 was 7.46 % and as of December 31, 2022 was 5.50 %. As of December 31, 2023 , the Company did no t have any outstanding balance against its 2023 Revolving Facility’s outstanding balance. The Company had $ 135.5 million of availability under the 2023 Revolving Facility as of December 31, 2023. During the three and six months ended December 31, 2023 the Company did no t make any additional payments against its term loan facility other than the scheduled payments per the terms of the 2023 Credit Agreement. During the six months ended December 31, 2022 , the Company made an additional payment of $ 30.0 million, against its term loan facility under the 2023 Credit Agreement. The Company h ad $ 14.5 million of outstanding letters of credit as of December 31, 2023 . |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 8. Commitments and Contingencies Purchase Commitments The Company currently has arrangements with contract manufacturers and suppliers for the manufacture of its products. Those arrangements allow the contract manufacturers to procure long lead-time component inventory based upon a rolling production forecast provided by the Company. The Company is obligated to purchase long lead-time component inventory that its contract manufacturer procures in accordance with the forecast, unless the Company gives notice of order cancellation outside of applicable component lead-times. As of December 31, 2023, the Company had commitments to purchase $ 92.1 million of inventory. Legal Proceedings The Company may from time to time be party to litigation arising in the course of its business, including, without limitation, allegations relating to commercial transactions, business relationships, or intellectual property rights. Such claims, even if not meritorious, could result in the expenditure of significant financial and managerial resources. Litigation in general, and intellectual property litigation in particular, can be expensive and disruptive to normal business operations. Moreover, the results of legal proceedings are difficult to predict. In accordance with applicable accounting guidance, the Company records accruals for certain of its outstanding legal proceedings, investigations or claims when it is probable that a liability will be incurred, and the amount of loss can be reasonably estimated. The Company evaluates, at least on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would result in a loss contingency to become both probable and reasonably estimable. When a loss contingency is not both probable and reasonably estimable, the Company does not record a loss accrual. However, if the loss (or an additional loss in excess of any prior accrual) is at least reasonably possible and material, then the Company would disclose an estimate of the possible loss or range of loss, if such estimate can be made, or disclose that an estimate cannot be made. The assessment whether a loss is probable or a reasonable possibility, and whether the loss or a range of loss is estimable, involves a series of complex judgments about future events. Even if a loss is reasonably possible, the Company may not be able to estimate a range of possible loss, particularly where (i) the damages sought are substantial or indeterminate, (ii) the proceedings are in the early stages, or (iii) the matters involve novel or unsettled legal theories or a large number of parties. In such cases, there is considerable uncertainty regarding the ultimate resolution of such matters, including the amount of any possible loss, fine or penalty. However, an adverse resolution of one or more of such matters could have a material adverse effect on the Company's results of operations in a particular quarter or fiscal year. Orckit IP, LLC v. Extreme Networks, Inc., Extreme Networks Ireland Ltd., and Extreme Networks GmbH On February 1, 2018, Orckit IP, LLC (“Orckit”) filed a patent infringement lawsuit against the Company and its Irish and German subsidiaries in the District Court in Dusseldorf, Germany. The lawsuit alleges direct and indirect infringement of the German portion of a patent (“EP ‘364”) based on the offer, distribution, use, possession and/or importation into Germany of certain network switches that are equipped with the ExtremeXOS operating system. Orckit is seeking injunctive relief, accounting, and an unspecified declaration of liability for damages and costs of the lawsuit. On January 28, 2020, the Court rendered a decision in the infringement case in favor of the Company. The matter is proceeding through the appellate process. On April 23, 2019, Orckit filed an extension of the patent infringement complaint against the Company and its Irish and German subsidiaries in the District Court in Dusseldorf, Germany. With this extension, Orckit alleges infringement of the German portion of a second patent (“EP ‘077”) based on the offer, distribution, use, possession and/or importation into Germany of certain network switches that the Company no longer sells in Germany. Orckit is seeking injunctive relief, accounting and sales information, and a declaration of liability for damages as well as costs of the lawsuit. On October 13, 2020, the Court issued an infringement decision against the Company and granted Orckit the right to enforce the judgment against the Company, which Orckit has provided notification to the Company that it will enforce the judgment. In the rendering of account, Orckit was informed that the products at issue were in end of sale status prior to the filing of the EP ‘077 complaint. The Company has appealed the infringement decision, and the matter is proceeding through the appellate process. The Company filed a nullity action related to the EP ‘364 patent on May 3, 2018, and one related to the EP ‘077 patent on October 31, 2019, both in the Federal Patent Court in Munich. The Federal Patent Court in Munich found the EP ‘364 patent to be valid and the Company filed an appeal, which was dismissed on October 12, 2023. On October 25, 2022 the Federal Patent Court in Munich issued an opinion partially invalidating the EP ‘077 patent and the Company and Orckit have filed appeals. SNMP Research, Inc. and SNMP Research International, Inc. v. Broadcom Inc., Brocade Communications Systems LLC, and Extreme Networks, Inc. On October 26, 2020, SNMP Research, Inc. and SNMP Research International, Inc. (collectively, “SNMP”) filed a lawsuit against the Company in the Eastern District of Tennessee for copyright infringement, alleging that the Company was not properly licensed to use its software. SNMP is seeking actual damages and profits attributed to the infringement, as well as equitable relief. The Company filed a motion to transfer the case to the Northern District of California. The motion to dismiss was denied in part and denied without prejudice in part. On March 2, 2023, SNMP filed an amended complaint adding claims against Extreme on additional products for copyright infringement, breach of contract, and fraud. On March 16, 2023, the Company filed a motion to dismiss, challenging multiple claims from the amended complaint. On March 20, 2023, the Company filed a motion to refer questions to the US Copyright Office on the invalidity of SNMP’s copyrights. The trial date has been set for October 2024. Mala Technologies Ltd. v. Extreme Networks GmbH, Extreme Networks Ireland Ops Ltd., and Extreme Networks, Inc. On April 15, 2021, Mala Technologies Ltd. (“Mala”) filed a patent infringement lawsuit against the Company and its Irish and German subsidiaries in the District Court in Dusseldorf, Germany. The lawsuit alleges indirect infringement of the German portion of a patent (“EP ‘498”) based on the offer and sale in Germany of certain network switches equipped with the ExtremeXOS operating system. Mala is seeking injunctive relief, accounting, and an unspecified declaration of liability for damages and costs of the lawsuit. On December 20, 2022, the trial court ruled that the Company did not infringe the EP ‘498 patent and dismissed Mala’s complaint entirely. Mala has filed an appeal and the matter is proceeding through the appellate process. The Company filed a nullity complaint against EP ‘498 with the German Federal Patent Court on September 24, 2021 and a hearing date has been set for November 20, 2024. Indemnification Obligations Subject to certain limitations, the Company may be obligated to indemnify its current and former directors, officers, and employees. These obligations arise under the terms of its certificate of incorporation, its bylaws, applicable contracts, and applicable law. The obligation to indemnify, where applicable, generally means that the Company is required to pay or reimburse, and in certain circumstances the Company has paid or reimbursed, the individuals’ reasonable legal expenses and possible damages and other liabilities incurred in connection with certain legal matters. The Company also procures Directors and Officers liability insurance to help cover its defense and/or indemnification costs, although its ability to recover such costs through insurance is uncertain. While it is not possible to estimate the maximum potential amount that could be owed under these governing documents and agreements due to the Company’s limited history with prior indemnification claims, indemnification (including defense) costs could, in the future, have a material adverse effect on the Company’s consolidated financial position, results of operations and cash flows. |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Stockholders' Equity | 9. Stockholders’ Equity Equity Incentive Plan The Compensation Committee of the Board unanimously approved an amendment to the Extreme Networks, Inc. Amended and Restated 2013 Equity Incentive Plan (the “2013 Plan”) on September 14, 2023 to increase the maximum number of available shares by 5.0 million shares. The amendment was approved by the stockholders of the Company at the annual meeting of stockholders held on November 8, 2023. Employee Stock Purchase Plan The Compensation Committee of the Board unanimously approved an amendment to the 2014 Employee Stock Purchase Plan (the “ESPP”) on September 9, 2021 to increase the maximum number of shares that will be available for sale thereunder by 7.5 million shares. The amendment was approved by the stockholders of the Company at the annual meeting of stockholders held on November 4, 2021. Common Stock Repurchases On May 18, 2022, the Company announced the Board had authorized management to repurchase up to $ 200.0 million shares of the Company’s common stock over a three-year period commencing July 1, 2022 (as amended, the “2022 Repurchase Program”). Initially, under the 2022 Repurchase Program, a maximum of $ 25.0 million of shares was authorized to be repurchased in any quarter; however, on November 17, 2022, the Board increased the authorization to repurchase shares in any quarter from up to $ 25.0 million of shares per quarter to up to $ 50.0 million of shares per quarter. Purchases may be made from time to time in the open market or pursuant to a 10b5-1 plan. During the three months ended December 31, 2023 , the Company repurchased 1,485,005 shares of its common stock on the open market at a total cost of $ 25.0 million with an average price of $ 16.81 per share. During the six months ended December 31, 2023 , the Company repurchased a total of 2,365,220 shares of its common stock on the open market at a total cost of $ 49.9 million with an average price of $ 21.08 per share. During the three and six months ended December 31, 2022 , the Company repurchased a total of 2,578,175 shares of its common stock on the open market at a total cost of $ 49.8 million with an average price of $ 19.32 per share. As of December 31, 2023, approximately $ 50.3 million remains available for share repurchases under the 2022 Repurchase Program. As a provision of the Inflation Reduction Act enacted in the U.S., the Company is subject to an excise tax on corporate stock repurchases, which is assessed as one percent of the fair market value of net corporate stock repurchases af ter December 31, 2022. The Company expects that the impact of the excise tax on net corporate stock repurchases will not be material for fiscal 2024. |
Employee Benefit Plans
Employee Benefit Plans | 6 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Employee Benefit Plans | 10. Employee Benefit Plans Shares Reserved for Issuance The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands): December 31, June 30, 2013 Equity Incentive Plan shares available for grant 12,634 9,995 Employee stock options and awards outstanding 8,875 10,038 2014 Employee Stock Purchase Plan 7,948 8,467 Total shares reserved for issuance 29,457 28,500 Share-based Compensation Expense Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Cost of product revenues $ 464 $ 499 $ 947 $ 873 Cost of subscription and support revenues 749 966 1,615 1,638 Research and development 4,435 3,962 8,812 7,052 Sales and marketing 7,535 5,910 14,523 10,549 General and administrative 7,774 6,059 14,979 11,073 Total share-based compensation expense $ 20,957 $ 17,396 $ 40,876 $ 31,185 Stock Options The following table summarizes stock option activity for the six months ended December 31, 2023 (in thousands, except per share amount and contractual term): Number of Shares Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value Options outstanding at June 30, 2023 1,187 $ 6.56 2.70 $ 23,136 Granted — — Exercised ( 57 ) 6.40 Canceled — — Options outstanding at December 31, 2023 1,130 $ 6.57 2.22 $ 12,513 Vested and expected to vest at December 31, 2023 1,130 $ 6.57 2.22 $ 12,513 Exercisable at December 31, 2023 1,130 $ 6.57 2.22 $ 12,513 The fair value of each stock option grant under the 2013 Plan is estimated on the date of grant using the Black-Scholes-Merton option valuation model. The expected term of options granted is derived from historical data on employee exercise and post-vesting employment termination behavior. The risk-free interest rate is based upon the estimated life of the option and the U.S. Treasury yield curve in effect at the time of grant. Expected volatility is based on the historical volatility on the Company’s stock. There were no stock options granted during the six months ended December 31, 2023 and 2022. Stock Awards Stock awards may be granted under the 2013 Plan on terms approved by the Compensation Committee of the Board. Stock awards generally provide for the issuance of restricted stock units (“RSUs”) including performance-condition or market-condition RSUs which vest over a fixed period of time or based upon the satisfaction of certain performance criteria or market conditions. The Company recognizes compensation expense on the stock awards over the vesting period based on the awards’ fair value as of the date of grant. The Company does not estimate forfeitures, but accounts for them as incurred. The following table summarizes stock award activity for the six months ended December 31, 2023 (in thousands, except grant date fair value): Number of Shares Weighted- Average Grant Date Fair Value Aggregate Fair Value Non-vested stock awards outstanding at June 30, 2023 8,851 $ 14.25 Granted 3,553 29.30 Released ( 4,114 ) 12.57 Canceled ( 545 ) 17.51 Non-vested stock awards outstanding at December 31, 2023 7,745 $ 21.81 $ 168,918 Stock awards expected to vest at December 31, 2023 7,745 $ 21.81 $ 168,918 The RSUs granted under the 2013 Plan vest over a period of time, generally one to three years, and are subject to participant's continued service to the Company. The stock awards granted during the six months ended December 31, 2023 included 0.6 million RSUs including the market condition awards discussed below to the named executive officers and directors. Market Condition Awards During the six months ended December 31, 2023 and 2022, the Compensation Committee of the Board granted 0.8 million and 1.0 million RSUs, respectively, with vesting based on market conditions (“MSU”) to certain of the Company’s executive officers. The MSUs granted during the six months ended December 31, 2023 included 0.5 million MSUs subject to total shareholder return (“TSR”) and 0.3 million MSUs subject to certain stock price targets. The MSUs granted during the six months ended December 31, 2022 were subject to TSR. The TSR MSUs vest based on the Company’s TSR relative to the TSR of the Russell 2000 Index (“Index”). The MSU award represents the right to receive a target number of shares of common stock of up to 150 % of the original grant, as indicated in the table below. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance. Level Relative TSR Shares Vested Below Threshold TSR is less than the Index by more than 37.5 percentage points 0 % Threshold TSR is less than the Index by 37.5 percentage points 25 % Target TSR equals the Index 100 % Maximum TSR is greater than the Index by 25 percentage points or more 150 % Total shareholder return is calculated based on the average closing price for the 30-trading days prior to the beginning and end of the performance periods. Performance is measured based on three periods, with the ability for up to one-third of target shares to vest after years one and two and the ability for up to the maximum of the full award to vest based on the full three-year TSR less any shares vested based on one- and two-year periods. Linear interpolation is used to determine the number of shares vested for achievement between target levels. The grant date fair value of each MSU was determined using the Monte Carlo simulation model. The weighted-average grant-date fair value of the TSR MSUs granted during the six months ended December 31, 2023 was $ 34.09 per share. The assumptions used in the Monte Carlo simulation included the expected volatility of 50 %, risk-free interest rate of 4.48 %, no expected dividend yield, expected term of three years and possible future stock prices over the performance period based on the historical stock and market prices. The weighted-average grant-date fair value of the TSR MSUs granted during the six months ended December 31, 2022 was $ 16.57 per share. The assumptions used in the Monte Carlo simulation included the expected volatility of 67 %, risk-free interest rate of 3.12 %, no expected dividend yield, expected term of three years , and possible future stock prices over the performance period based on the historical stock and market prices. The Company recognizes the expense related to these MSUs on a graded-vesting method over the estimated term. The stock price target MSUs vest upon the achievement of a certain stock price target over the defined performance period. The stock price target shall be deemed as achieved if the average closing stock price over any thirty consecutive trading days during the period from grant date through the third anniversary of the grant date equals or exceeds the price target of $ 41.38 for the initial performance period. Upon satisfaction of the initial stock price target, 50 % of the target shares will vest on the 3rd anniversary of the grant date and the remaining 50 % will vest on the 4th anniversary of the grant date, subject to employees continued service through the applicable vesting dates. If the units are not earned on the last day of initial performance period, the units will remain outstanding and be eligible to be earned if the average closing stock price over any thirty consecutive trading days equals or exceeds the price target of $ 46.96 . The grant date fair value of these stock price target MSUs was determined using the Monte Carlo simulation model. The weighted-average grant-date fair value of these stock price target MSUs granted during the six months ended December 31, 2023 was $ 28.80 per share. The assumptions used in the Monte Carlo simulation included the expected volatility of 63 %, risk-free interest rate of 4.45 %, no expected dividend yield, expected term of three years based on possible future stock prices over the performance period based on the historical stock prices. The Company recognizes the expense related to these MSUs on a graded-vesting method over the estimated term. Employee Stock Purchase Plan The fair value of each share purchase option under the ESPP is estimated on the date of grant using the Black-Scholes-Merton option valuation model with the weighted average assumptions noted in the following table. The expected term of the ESPP represents the term of the offering period of each option. The risk-free interest rate is based on the estimated life and on the U.S. Treasury yield curve in effect at the time of grant. Expected volatility is based on the historical volatility on the Company’s common stock. There were 0.5 million and 0.7 million shares issued under the ESPP during t he six months ended December 31, 2023 and 2022, respectively. The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods: Employee Stock Purchase Plan Six Months Ended December 31, December 31, Expected term 0.5 years 0.5 years Risk-free interest rate 5.54 % 3.12 % Volatility 42 % 60 % Dividend yield — % — % The weighted-average grant-date fair value of shares under the ESPP during the six months ended December 31, 2023 and 2022 was $ 8.09 a nd $ 4.38 per share, respectively. |
Information about Segments and
Information about Segments and Geographic Areas | 6 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Information about Segments and Geographic Areas | 11. Information about Segments and Geographic Areas The Company operates in one segment, the development and marketing of network infrastructure equipment and related software. The Company conducts business globally and is managed geographically. Revenues are attributed to a geographical area based on the billing address of customers. The Company operates in three geographical areas: Americas, EMEA, and APAC. The Company’s chief operating decision maker, who is its Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. See Note 3, Revenues, for the Company’s revenues by geographic regions and channel based on the customer’s billing address. The Company’s long-lived assets are attributed to the geographic regions as follows (in thousands): December 31, June 30, Americas $ 140,161 $ 124,375 EMEA 37,335 35,175 APAC 11,313 11,244 Total long-lived assets $ 188,809 $ 170,794 |
Derivatives and Hedging
Derivatives and Hedging | 6 Months Ended |
Dec. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives and Hedging | 12. Derivatives and Hedging Interest Rate Swaps The Company is exposed to interest rate risk on its debt. The Company may enter into interest rate swap contracts to effectively manage the impact of fluctuations of interest rate changes on its outstanding debt which may have floating interest rate. The Company does not enter into derivative contracts for trading or speculative purposes. At the inception date of the derivative contract, the Company performs an assessment of these contracts and has designated these contracts as cash flow hedges. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreement without exchange of the underlying notional amount. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, by performing qualitative and quantitative assessments of whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flow of hedged items. Changes in the fair value of a derivative that is qualified, designated and highly effective as a cash flow hedge are recorded in other comprehensive income (loss). When it is determined that a derivative is not highly effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively. In accordance with ASC 815 Derivatives and Hedging , the Company may prospectively discontinue the hedge accounting for an existing hedge if the applicable criteria are no longer met, the derivative instrument expires, is sold, terminated or exercised or if the Company removes the designation of the respective cash flow hedge. In those circumstances, the net gain or loss remains in “Accumulated other comprehensive loss” and is reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings, unless the forecasted transaction is no longer probable in which case the net gain or loss is reclassified into earnings immediately. During the fiscal year ended June 30, 2020, the Company entered into multiple interest rate swap contracts, designated as cash flow hedges, to hedge the variability of cash flows in interest payments associated with the Company’s various tranches of floating-rate debt. As of December 31, 2023 , the Company did no t have any outstanding interest rate swaps contracts. As of December 31 , 2022 , the notional amount of these interest rate swaps was $ 75.0 million, and had maturity dates through April 2023 . As of December 31 , 2022, these contracts had unrealized gains of $ 0.8 million, and were recorded in “Accumulated other comprehensive loss” with the associated asset in “Prepaid expenses and other current assets”, in the condensed consolidated balance sheets. Cash flows associated with periodic settlements of interest rate swaps are classified as operating activities in the condensed consolidated statement of cash flows. Realized gains and losses are recognized as they accrue in interest expense. Amounts reported in “Accumulated other comprehensive loss” related to these cash flow hedges are reclassified to interest expense over the life of the swap contracts. Foreign Exchange Forward Contracts The Company uses derivative financial instruments to manage exposures to foreign currency that may or may not be designated as hedging instruments. The Company’s objective for holding derivatives is to use the most effective methods to minimize the impact of these exposures. The Company does not enter into derivatives for speculative or trading purposes. The Company enters into foreign exchange forward contracts primarily to mitigate the effect of gains and losses generated by foreign currency transactions related to certain operating expenses and re-measurement of certain assets and liabilities denominated in foreign currencies. For foreign exchange forward contracts not designated as hedging instruments, the fair value of the Company’s derivatives in a gain position are recorded in “Prepaid expenses and other current assets” and derivatives in a loss position are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. Changes in the fair value of derivatives are recorded in “Other income (expense), net” in the accompanying condensed consolidated statements of operations. As of December 31, 2023 and 2022, foreign exchange forward contracts not designated as hedging instruments had a total notional principal amount of $ 15.6 million and $ 11.1 million, respectively. These contracts have maturities of 40 days or less. During the three months ended December 31, 2023 and 2022, the net gains and losses recorded in the condensed consolidated statement of operations from these contracts were net gains of $ 0.4 million and $ 0.1 million, respectively. During the six months ended December 31, 2023 and 2022 the net gains and losses recorded in the condensed consolidated statement of operations were net gains of $ 0.3 million and net losses of $ 0.4 million, respectively. Changes in the fair value of these foreign exchange forward contracts are offset largely by remeasurement of the underlying assets and liabilities. For the three months ended December 31, 2023 and 2022 , the Company recognized total foreign currency losses of $ 0.7 million and total foreign currency gains of less than $ 0.1 million, respectively, and f or the six months ended December 31, 2023 and 2022 , the Company recognized total foreign currency losses of $ 0.3 million and total foreign currency gains of $ 0.8 million, respectively, related to the change in fair value of foreign currency denominated assets and liabilities. |
Restructuring and Related Charg
Restructuring and Related Charges | 6 Months Ended |
Dec. 31, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Related Charges | 13. Restructuring and Related Charges The Company recorded $ 9.2 million and $ 11.9 million of restructuring and related charges during the three and six months ended December 31, 2023, respectively, which primarily related to the restructuring plans as noted below. During the second quarter of fiscal 2024, the Company executed a global reduction-in-force plan to rebalance its workforce to create greater efficiency and improve execution, in alignment with the Company's business and strategic priorities, while reducing its ongoing operating expenses to address reduced revenue and macro-economic conditions (the “Q2 2024 Plan”). During the three months ended December 31, 2023, the Company recorded restructuring charges of approximately $ 8.8 million related to the Q2 2024 Plan, which primarily consisted of severance and benefits expenses. The Company expects to complete this Plan by the end of fiscal 2024 and expects to incur an additional $ 4.5 million in charges by the end of fiscal 2024. During the first quarter of fiscal 2024, the Company initiated a reduction-in-force plan to rebalance the workforce to create greater efficiency and improve execution in alignment with the Company's business and strategic priorities (the “Q1 2024 Plan”). It consisted primarily of workforce reduction to drive productivity in research and development, sales and marketing and provide efficiency across operations and general & administrative functions. During the three and six months ended December 31, 2023, the Company incurred charges of approximately $ 0.2 million and $ 2.9 million, respectively related to the Q1 2024 Plan. As of December 31, 2023, the plan is substantially completed. During the third quarter of fiscal 2023, the Company initiated a restructuring plan to transform its business infrastructure and reduce its facilities footprint and the facilities related charges (the “2023 Plan”). As part of this project, the Company is moving engineering labs from its San Jose, California location to its Salem, New Hampshire location. This move is expected to help reduce the cost of operating the Company's labs. During the three months and six months ended December 31, 2023, the Company incurred restructuring charges of approximatel y $ 0.2 million pri marily for move costs. The Company expects that the project will take about 9 to 12 months from December 31, 2023 to complete, and expects to incur charges of approximately $ 10.0 million throughout this period, primarily for asset disposals, contractor costs, severance, relocation, and other non-recurring fees. The Company recorded $ 0.5 million and $ 1.0 million of restructuring and related charges during the three and six months ended December 31, 2022, which primarily included additional facilities expenses related to previously impaired facilities. Restructuring liabilities are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. As of December 31, 2023, the restructuring liability was $ 6.2 million, which primarily related to the Q2 2024 Plan. |
Income Taxes
Income Taxes | 6 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 14. Income Taxes For the three months ended December 31, 2023 and 2022, the Company recorded an income tax provision of $ 3.1 million and $ 2.6 million, respectively . For the six months ended December 31, 2023 and 2022 , the Company recorded an income tax provision of $ 7.6 million and $ 4.4 million, respectively. The income tax provisions for the three and six months ended December 31, 2023 and 2022, consisted of (1) taxes on the income of the Company’s foreign subsidiaries, (2) state taxes in jurisdictions where the Company has no remaining state net operating losses (“NOLs”), (3) foreign withholding taxes, and (4) tax expense associated with the establishment of a U.S. deferred tax liability for amortizable goodwill resulting from the acquisition of Enterasys Networks, Inc., the wireless local area network business from Zebra Technologies Corporation, the Campus Fabric Business from Avaya and the Data Center Business from Brocade. In addition, the tax provision for the three and six months ended December 31, 2023 , includes US Federal income tax of $ 0.2 million and $ 1.6 million, respectively. The interim income tax provisions for the three and six months ended December 31, 2023 and 2022 were calculated using the discrete effective tax rate method as allowed by ASC 740-270-30-18, Income Taxes – Interim Reporting . The discrete method is applied when the application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. The discrete method treats the year-to-date period as if it was the annual period and determines the income tax expense or benefit on that basis. The Company believes that, at this time, the use of this discrete method is more appropriate than the annual effective tax rate method as (i) the estimated annual effective tax rate method is not reliable due to the high degree of uncertainty in estimating annual pretax earnings on a jurisdictional basis and (ii) the Company’s ongoing assessment that the recoverability of certain U.S. and Irish deferred tax assets is not more likely than not. The Company has provided a full valuation allowance against all of its U.S. federal and state deferred tax assets as well as a portion of the deferred tax assets in Ireland. Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, the Company considers all available positive and negative evidence to determine whether it is “more likely than not” that deferred tax assets are recoverable including past operating results, estimates of future taxable income, changes to enacted tax laws, and the feasibility of tax planning strategies; such assessment is required on a jurisdiction-by-jurisdiction basis. The Company's inconsistent earnings in recent periods, including historical losses, tax attributes expiring unutilized in recent years and the cyclical nature of the Company's business provides sufficient negative evidence that require a full valuation allowance against its U.S. federal and state net deferred tax assets as well as a portion of the deferred tax assets in Ireland. These valuation allowances will be evaluated periodically and can be reversed partially or in whole if business results and the economic environment have sufficiently improved to support realization of some or all of the Company's deferred tax assets. In the event the Company changes its determination as to the amount of deferred tax assets that can be realized, it will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made. The Company h ad $ 18.3 million of unrecognized tax benefits as of December 31, 2023 . If fully recognized in the future, $ 0.2 million would impact the effective tax rate and $ 18.1 million would result in adjustments to deferred tax assets and corresponding adjustments to the valuation allowance with no impact to the effective tax rate. The Company does not anticipate any events to occur during the next twelve months that would materially reduce the unrealized tax benefit as currently stated in the Company’s condensed consolidated balance sheets. The Company’s policy is to accrue interest and penalties related to the underpayment of income taxes as a component of tax expense in the accompanying condensed consolidated statements of operations. In general, the Company’s U.S. federal income tax returns are subject to examination by tax authorities for fiscal years 2001 forward due to NOLs and the Company’s state income tax returns are subject to examination for fiscal years 2000 and forward due to NOLs. The Company is not currently under audit for income tax purposes in any material jurisdictions. |
Net Income Per Share
Net Income Per Share | 6 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | 15. Net Income Per Share Basic net income per share is calculated by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted-average number of shares of common stock used in the basic net income per share calculation plus the dilutive effect of shares subject to repurchase, options and unvested RSUs. The following table presents the calculation of net income per share of basic and diluted (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Net income $ 3,988 $ 17,931 $ 32,664 $ 30,516 Weighted-average shares used in per share calculation – basic 128,987 130,465 128,885 130,377 Options to purchase common stock 757 717 836 635 Restricted stock units 1,579 3,164 2,951 2,760 Employee Stock Purchase Plan shares 191 107 114 61 Weighted-average shares used in per share calculation – diluted 131,514 134,453 132,786 133,833 Net income per share – basic and diluted Net income per share – basic $ 0.03 $ 0.14 $ 0.25 $ 0.23 Net income per share – diluted $ 0.03 $ 0.13 $ 0.25 $ 0.23 The following securities were excluded from the computation of net income per diluted share of common stock for the periods presented as their effect would have been anti-dilutive (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Restricted stock units 2,336 437 1,623 306 Employee Stock Purchase Plan shares 560 678 445 529 Total shares excluded 2,896 1,115 2,068 835 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Fiscal Year | Fiscal Year The Company uses a fiscal calendar year ending on June 30. All references herein to “fiscal 2024” represent the fiscal year ending June 30, 2024. All references herein to “fiscal 2023” represent the fiscal year ended June 30, 2023 . |
Principles of Consolidation | Principles of Consolidation The unaudited condensed consolidated financial statements include the accounts of Extreme and its wholly owned subsidiaries. All inter-company accounts and transactions have been eliminated. The Company predominantly uses the United States Dollar as its functional currency. The functional currency for certain of its foreign subsidiaries is the local currency. For those subsidiaries that operate in a local functional currency environment, all assets and liabilities are translated to United States Dollars at current month end rates of exchange and revenues, and expenses are translated using the monthly average rate. |
Accounting Estimates | Accounting Estimates The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements There were no recently adopted accounting standards which would have a material effect on our condensed consolidated financial statements and accompanying disclosures. Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods for fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2023-07 on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures to enhance income tax disclosures primarily through changes in the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2023-09 on its consolidated financial statements and related disclosures . |
Revenue Recognition | Revenue Recognition Performance Obligations. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Certain of the Company’s contracts have multiple performance obligations, as the promise to transfer individual goods or services is separately identifiable from other promises in the contracts and, therefore, is distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which the Company separately sells these products. For items that are not sold separately, the Company estimates the stand-alone selling prices using other observable inputs . The Company’s performance obligations are satisfied at a point in time or over time as the customer receives and consumes the benefits provided. Substantially all of the Company’s product sales revenues are recognized at a point in time. Substantially all of the Company’s subscription and support revenues are recognized over time. For revenues recognized over time, the Company uses an input measure, days elapsed, to measure progress. On December 31, 2023, the Company had $ 548.2 million of remaining performance obligations, which primarily comprised deferred maintenance and deferred SaaS revenues. The Company expects to recognize approximat ely 32 % of its deferred revenue as revenue in the remainder of fiscal 2024 , an additional 34 % in fiscal 2025, and 34 % of the balance thereafter . Contract Balances. The timing of revenue recognition, billings and cash collections results in billed accounts receivable and deferred revenue in the condensed consolidated balance sheets. Services provided under renewable support arrangements of the Company are billed in accordance with agreed-upon contractual terms, which are either billed fully at the inception of contract or at periodic intervals (e.g., quarterly or annually). The Company generally receives payments from its customers in advance of services being provided, resulting in deferred revenues. These liabilities are reported on the condensed consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. Revenue recognized for the three months ended December 31, 2023 and 2022 that was included in the deferred revenue balance at the beginning of each period w as $ 105.7 million and $ 83.9 million, respectively. Revenue recognized for the six months ended December 31, 2023 and 2022 that was included in the deferred revenue balance at the beginning of each period was $ 172.0 million and $ 145.7 million, respectively. Contract Costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Management expects that commission fees paid to sales representatives as a result of obtaining subscription and support contracts and contract renewals are recoverable and therefore the Company’s condensed consolidated balance sheets included capitalized balances in the amount of $ 22.2 million and $ 20.0 million at December 31, 2023 and June 30, 2023 , respectively. Capitalized commissions are included within other assets in the condensed consolidated balance sheets. Capitalized commission fees are amortized on a straight-line basis over the average period of service contracts of approximately three years , and are included in “Sales and marketing” in the accompanying condensed consolidated statements of operations. Amortization recognized during the three months ended December 31, 2023 and 2022 was $ 2.7 million and $ 2.2 million, respectively. Amortization recognized during the six months ended December 31, 2023 and 2022 was $ 5.2 million and $ 4.3 million, respectively. Estimated Variable Consideration. There were no material changes in the current period to the estimated variable consideration for performance obligations, which were satisfied or partially satisfied during previous periods. Revenues by Category The Company operates in three geographic regions: Americas, EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific). The following table sets forth the Company’s net revenues disaggregated by sales channel and geographic region based on the billing addresses of its customers (in thousands): Three Months Ended December 31, December 31, Distributor Direct Total Distributor Direct Total Americas: United States $ 81,350 $ 68,199 $ 149,549 $ 70,963 $ 66,630 $ 137,593 Other 8,244 4,842 13,086 10,807 4,614 15,421 Total Americas 89,594 73,041 162,635 81,770 71,244 153,014 EMEA 64,082 46,523 110,605 97,147 40,903 138,050 APAC 8,864 14,273 23,137 7,403 19,881 27,284 Total net revenues $ 162,540 $ 133,837 $ 296,377 $ 186,320 $ 132,028 $ 318,348 Six Months Ended December 31, December 31, Distributor Direct Total Distributor Direct Total Americas: United States $ 199,151 $ 133,150 $ 332,301 $ 144,277 $ 130,942 $ 275,219 Other 10,775 15,208 25,983 26,832 8,712 35,544 Total Americas 209,926 148,358 358,284 171,109 139,654 310,763 EMEA 166,393 87,815 254,208 173,403 80,156 253,559 APAC 8,975 28,047 37,022 9,441 42,274 51,715 Total net revenues $ 385,294 $ 264,220 $ 649,514 $ 353,953 $ 262,084 $ 616,037 For the three months ended December 31, 2023, the Company generated 10 % of its net revenues from Germany. For the six months ended December 31, 2023 , the Company generated approximately 11 % of its net revenues from the Netherlands. For the three months ended December 31, 2022, the Company generated 11 % and 10 % of its net revenues from the Netherlands and Germany, respectively. For the six months ended December 31, 2022, the Company generated 10 % of its net revenues from each of the Netherlands and Germany. No other foreign country accounted for 10 % or more of its net revenues for the three and six months ended December 31, 2023 and 2022 . |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers highly liquid investments with maturities of three months or less at the date of purchase to be cash equivalents. The following table summarizes the Company's cash and cash equivalents (in thousands): December 31, June 30, Cash $ 211,526 $ 227,675 Cash equivalents 9,877 7,151 Total cash and cash equivalents $ 221,403 $ 234,826 |
Inventories | Inventories Inventories are stated at the lower of cost, or net realizable value. Extreme uses a standard cost methodology to determine the cost basis for its inventories. Cost is computed using standard cost, which approximates actual cost, on a first-in, first-out basis. The Company adjusts the carrying value of its inventory when conditions exist that suggest that inventory may be in excess of anticipated demand or is obsolete based upon assumptions about future demand. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. Any previously written down or obsolete inventory subsequently sold has not had a material impact on gross margin for any of the periods presented. The following table summarizes the Company's inventory by category (in thousands): December 31, June 30, Finished goods $ 124,668 $ 78,180 Raw materials 27,853 10,844 Total inventories $ 152,521 $ 89,024 |
Property and Equipment, Net | Property and Equipment, Net The following table summarizes the Company's property and equipment, net by category (in thousands): December 31, June 30, Computers and equipment $ 83,633 $ 81,612 Purchased software 54,378 51,444 Office equipment, furniture and fixtures 9,002 8,899 Leasehold improvements 51,563 48,943 Total property and equipment 198,576 190,898 Less: accumulated depreciation and amortization ( 150,978 ) ( 144,450 ) Property and equipment, net $ 47,598 $ 46,448 |
Deferred Revenue | Deferred Revenue Deferred revenue represents invoiced amounts for deferred maintenance, SaaS, and other deferred revenue including professional services and training when the revenue recognition criteria have not been met. |
Guarantees and Product Warranties | Guarantees and Product Warranties The majority of the Company’s hardware products are shipped with either a one-year warranty or a limited lifetime warranty, and software products receive a 90 -day warranty. Upon shipment of products to its customers, the Company estimates expenses for the cost to repair or replace products that may be returned under warranty and accrues a liability in cost of product revenues for this amount. The determination of the Company’s warranty requirements is based on actual historical experience with the product or product family, estimates of repair and replacement costs, and any product warranty problems that are identified after shipment. The Company estimates and adjusts these accruals at each balance sheet date in accordance with changes in these factors. The following table summarizes the activity related to the Company’s product warranty liability during the following periods (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Balance beginning of period $ 12,164 $ 11,522 $ 12,322 $ 10,852 New warranties issued 2,777 3,807 6,451 7,815 Warranty expenditures ( 3,544 ) ( 3,509 ) ( 7,376 ) ( 6,847 ) Balance end of period $ 11,397 $ 11,820 $ 11,397 $ 11,820 To facilitate sales of its products in the normal course of business, the Company indemnifies its resellers and end-user customers with respect to certain matters. The Company has agreed to hold the customer harmless against losses arising from intellectual property infringement and certain other losses. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. It is not possible to estimate the maximum potential amount under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under these agreements have not had a material impact on its operating results or financial position. |
Concentrations | Concentrations The Company may be subject to concentration of credit risk as a result of certain financial instruments consisting of accounts receivable. See Note 3, Revenues, for the Company’s accounts receivable concentration. The Company does not invest an amount exceeding 10 % of its combined cash in the securities of any one obligor or maker, except for obligations of the United States government, obligations of United States government agencies, and money market accounts. |
Earnings Per Share | Basic net income per share is calculated by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted-average number of shares of common stock used in the basic net income per share calculation plus the dilutive effect of shares subject to repurchase, options and unvested RSUs. |
Revenues (Tables)
Revenues (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Revenues Disaggregated by Sales Channel and Geographic Region | The following table sets forth the Company’s net revenues disaggregated by sales channel and geographic region based on the billing addresses of its customers (in thousands): Three Months Ended December 31, December 31, Distributor Direct Total Distributor Direct Total Americas: United States $ 81,350 $ 68,199 $ 149,549 $ 70,963 $ 66,630 $ 137,593 Other 8,244 4,842 13,086 10,807 4,614 15,421 Total Americas 89,594 73,041 162,635 81,770 71,244 153,014 EMEA 64,082 46,523 110,605 97,147 40,903 138,050 APAC 8,864 14,273 23,137 7,403 19,881 27,284 Total net revenues $ 162,540 $ 133,837 $ 296,377 $ 186,320 $ 132,028 $ 318,348 Six Months Ended December 31, December 31, Distributor Direct Total Distributor Direct Total Americas: United States $ 199,151 $ 133,150 $ 332,301 $ 144,277 $ 130,942 $ 275,219 Other 10,775 15,208 25,983 26,832 8,712 35,544 Total Americas 209,926 148,358 358,284 171,109 139,654 310,763 EMEA 166,393 87,815 254,208 173,403 80,156 253,559 APAC 8,975 28,047 37,022 9,441 42,274 51,715 Total net revenues $ 385,294 $ 264,220 $ 649,514 $ 353,953 $ 262,084 $ 616,037 |
Schedule of Customers Accounting for 10% or More of Net Revenues and Accounts Receivable Balance | The following table sets forth customers accounting for 10% or more of the Company’s net revenues for the periods indicated below: Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Jenne, Inc. 23 % 13 % 25 % 13 % Westcon Group, Inc. 10 % 19 % 18 % 17 % TD Synnex Corporation 24 % 17 % 21 % 18 % ScanSource, Inc. * 11 % * * * Less than 10% of revenue The following table sets forth major customers accounting for 10% or more of the Company’s net accounts receivable balance: December 31, June 30, Jenne, Inc. 52 % 39 % TD Synnex Corporation * 10 % ScanSource, Inc. * 10 % Ingram Micro 10 % * * Less than 10% of accounts receivable |
Balance Sheet Accounts (Tables)
Balance Sheet Accounts (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Summary of Cash and Cash Equivalents | The following table summarizes the Company's cash and cash equivalents (in thousands): December 31, June 30, Cash $ 211,526 $ 227,675 Cash equivalents 9,877 7,151 Total cash and cash equivalents $ 221,403 $ 234,826 |
Components of Inventories | The following table summarizes the Company's inventory by category (in thousands): December 31, June 30, Finished goods $ 124,668 $ 78,180 Raw materials 27,853 10,844 Total inventories $ 152,521 $ 89,024 |
Components of Property and Equipment | The following table summarizes the Company's property and equipment, net by category (in thousands): December 31, June 30, Computers and equipment $ 83,633 $ 81,612 Purchased software 54,378 51,444 Office equipment, furniture and fixtures 9,002 8,899 Leasehold improvements 51,563 48,943 Total property and equipment 198,576 190,898 Less: accumulated depreciation and amortization ( 150,978 ) ( 144,450 ) Property and equipment, net $ 47,598 $ 46,448 |
Summary of Product Warranty Liability Activity | The following table summarizes the activity related to the Company’s product warranty liability during the following periods (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Balance beginning of period $ 12,164 $ 11,522 $ 12,322 $ 10,852 New warranties issued 2,777 3,807 6,451 7,815 Warranty expenditures ( 3,544 ) ( 3,509 ) ( 7,376 ) ( 6,847 ) Balance end of period $ 11,397 $ 11,820 $ 11,397 $ 11,820 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value for Financial Assets and Liabilities Measured on Recurring Basis | The following table presents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis at December 31, 2023 and June 30, 2023 (in thousands): December 31, 2023 Level 1 Level 2 Level 3 Total Assets Certificates of deposit $ — $ 9,877 $ — $ 9,877 Foreign currency derivatives — 133 — 133 Total assets measured at fair value $ — $ 10,010 $ — $ 10,010 June 30, 2023 Level 1 Level 2 Level 3 Total Assets Certificates of deposit $ — $ 7,151 $ — $ 7,151 Foreign currency derivatives — 31 — 31 Total assets measured at fair value $ — $ 7,182 $ — $ 7,182 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Components of Gross and Net Intangible Asset Balances | Intangible Assets The following tables summarize the components of gross and net intangible assets (in thousands, except years): Weighted Average Remaining Amortization Gross Carrying Accumulated Net Carrying Period Amount Amortization Amount December 31, 2023 Developed technology 4.1 years $ 169,646 $ 161,690 $ 7,956 Customer relationships 2.9 years 64,721 59,787 4,934 Trade names 0 years 10,700 10,700 — License agreements 2.9 years 2,445 2,231 214 Total intangible assets, net* $ 247,512 $ 234,408 $ 13,104 * The carrying amount of foreign intangible assets are affected by foreign currency translation Weighted Average Remaining Amortization Gross Carrying Accumulated Net Carrying Period Amount Amortization Amount June 30, 2023 Developed technology 4.1 years $ 169,460 $ 159,592 $ 9,868 Customer relationships 3.4 years 64,839 58,894 5,945 Trade names 0 years 10,700 10,700 — License agreements 3.4 years 2,445 2,195 250 Total intangible assets, net* $ 247,444 $ 231,381 $ 16,063 * The carrying amount of foreign intangible assets are affected by foreign currency translation |
Summary of Amortization Expense of Intangibles | The following table summarizes the amortization expense of intangible assets for the periods presented (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Amortization of intangible assets in “Total cost of revenues” $ 611 $ 3,220 $ 2,044 $ 6,825 Amortization of intangible assets in “Total operating expenses” 509 504 1,020 1,027 Total amortization expense $ 1,120 $ 3,724 $ 3,064 $ 7,852 |
Schedule of Expected Amortization Expenses | The estimated future amortization expense to be recorded for each of the respective future fiscal years is as follows (in thousands): Amount For the fiscal year ending June 30: 2024 (the remainder of fiscal 2024) $ 2,585 2025 4,414 2026 3,165 2027 1,418 2028 1,259 Thereafter 263 Total $ 13,104 |
Summary of Goodwill | The Company had Goodwill in the amount of $ 395.6 million and $ 394.8 million as of December 31, 2023 and June 30, 2023, respectively. The change in goodwill during the six months ended December 31, 2023 is due to foreign currency translation adjustment that is recorded as a component of accumulated other comprehensive loss. |
Debt (Tables)
Debt (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Components of Debt | The Company’s debt is comprised of the following (in thousands): December 31, June 30, Current portion of long-term debt: Term Loan $ 10,000 $ 10,000 Revolving Facility — 25,000 Less: unamortized debt issuance costs ( 675 ) ( 674 ) Current portion of long-term debt $ 9,325 $ 34,326 Long-term debt, less current portion: Term Loan $ 185,000 $ 190,000 Less: unamortized debt issuance costs ( 2,069 ) ( 2,409 ) Total long-term debt, less current portion 182,931 187,591 Total debt $ 192,256 $ 221,917 |
Employee Benefit Plans (Tables)
Employee Benefit Plans (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Common Stock Reserved for Future Issuance | The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands): December 31, June 30, 2013 Equity Incentive Plan shares available for grant 12,634 9,995 Employee stock options and awards outstanding 8,875 10,038 2014 Employee Stock Purchase Plan 7,948 8,467 Total shares reserved for issuance 29,457 28,500 |
Schedule of Recognized Share-based Compensation Expense | Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Cost of product revenues $ 464 $ 499 $ 947 $ 873 Cost of subscription and support revenues 749 966 1,615 1,638 Research and development 4,435 3,962 8,812 7,052 Sales and marketing 7,535 5,910 14,523 10,549 General and administrative 7,774 6,059 14,979 11,073 Total share-based compensation expense $ 20,957 $ 17,396 $ 40,876 $ 31,185 |
Summary of Stock Option Activity | The following table summarizes stock option activity for the six months ended December 31, 2023 (in thousands, except per share amount and contractual term): Number of Shares Weighted-Average Exercise Price Per Share Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value Options outstanding at June 30, 2023 1,187 $ 6.56 2.70 $ 23,136 Granted — — Exercised ( 57 ) 6.40 Canceled — — Options outstanding at December 31, 2023 1,130 $ 6.57 2.22 $ 12,513 Vested and expected to vest at December 31, 2023 1,130 $ 6.57 2.22 $ 12,513 Exercisable at December 31, 2023 1,130 $ 6.57 2.22 $ 12,513 |
Summary of Stock Award Activity | The following table summarizes stock award activity for the six months ended December 31, 2023 (in thousands, except grant date fair value): Number of Shares Weighted- Average Grant Date Fair Value Aggregate Fair Value Non-vested stock awards outstanding at June 30, 2023 8,851 $ 14.25 Granted 3,553 29.30 Released ( 4,114 ) 12.57 Canceled ( 545 ) 17.51 Non-vested stock awards outstanding at December 31, 2023 7,745 $ 21.81 $ 168,918 Stock awards expected to vest at December 31, 2023 7,745 $ 21.81 $ 168,918 |
Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs) | The MSU award represents the right to receive a target number of shares of common stock of up to 150 % of the original grant, as indicated in the table below. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance. Level Relative TSR Shares Vested Below Threshold TSR is less than the Index by more than 37.5 percentage points 0 % Threshold TSR is less than the Index by 37.5 percentage points 25 % Target TSR equals the Index 100 % Maximum TSR is greater than the Index by 25 percentage points or more 150 % |
Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards | The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods: Employee Stock Purchase Plan Six Months Ended December 31, December 31, Expected term 0.5 years 0.5 years Risk-free interest rate 5.54 % 3.12 % Volatility 42 % 60 % Dividend yield — % — % |
Information about Segments an_2
Information about Segments and Geographic Areas (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Long Lived Assets by Segment | The Company’s long-lived assets are attributed to the geographic regions as follows (in thousands): December 31, June 30, Americas $ 140,161 $ 124,375 EMEA 37,335 35,175 APAC 11,313 11,244 Total long-lived assets $ 188,809 $ 170,794 |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 6 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table presents the calculation of net income per share of basic and diluted (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Net income $ 3,988 $ 17,931 $ 32,664 $ 30,516 Weighted-average shares used in per share calculation – basic 128,987 130,465 128,885 130,377 Options to purchase common stock 757 717 836 635 Restricted stock units 1,579 3,164 2,951 2,760 Employee Stock Purchase Plan shares 191 107 114 61 Weighted-average shares used in per share calculation – diluted 131,514 134,453 132,786 133,833 Net income per share – basic and diluted Net income per share – basic $ 0.03 $ 0.14 $ 0.25 $ 0.23 Net income per share – diluted $ 0.03 $ 0.13 $ 0.25 $ 0.23 |
Schedule of Antidilutive Securities Excluded from Earnings Per Share Calculation | The following securities were excluded from the computation of net income per diluted share of common stock for the periods presented as their effect would have been anti-dilutive (in thousands): Three Months Ended Six Months Ended December 31, December 31, December 31, December 31, Restricted stock units 2,336 437 1,623 306 Employee Stock Purchase Plan shares 560 678 445 529 Total shares excluded 2,896 1,115 2,068 835 |
Revenues (Narratives) (Details)
Revenues (Narratives) (Details) $ in Millions | 3 Months Ended | 6 Months Ended | |||
Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2023 USD ($) Distribution_Channels | Dec. 31, 2022 USD ($) | Jun. 30, 2023 USD ($) | |
Disaggregation Of Revenue [Line Items] | |||||
Number of distribution channels | Distribution_Channels | 2 | ||||
Estimated selling price determination approach | Certain of the Company’s contracts have multiple performance obligations, as the promise to transfer individual goods or services is separately identifiable from other promises in the contracts and, therefore, is distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which the Company separately sells these products. For items that are not sold separately, the Company estimates the stand-alone selling prices using other observable inputs | ||||
Remaining revenue performance obligations | $ 548.2 | $ 548.2 | |||
Revenue recognized for deferred revenue balance | $ 105.7 | $ 83.9 | $ 172 | $ 145.7 | |
Geographic Concentration Risk | Revenue | NETHERLANDS | |||||
Disaggregation Of Revenue [Line Items] | |||||
Concentration risk (percent) | 11% | 11% | 10% | ||
Geographic Concentration Risk | Revenue | GERMANY | |||||
Disaggregation Of Revenue [Line Items] | |||||
Concentration risk (percent) | 10% | 10% | 10% | ||
Geographic Concentration Risk | Revenue | Other Foreign Country | Maximum | |||||
Disaggregation Of Revenue [Line Items] | |||||
Concentration risk (percent) | 10% | 10% | 10% | 10% | |
Commission Fees | |||||
Disaggregation Of Revenue [Line Items] | |||||
Revenue, practical expedient, incremental cost of obtaining contract [true false] | true | ||||
Contract costs capitalized, balances amount | $ 22.2 | $ 22.2 | $ 20 | ||
Contract costs capitalized, amortization period | 3 years | 3 years | |||
Contract costs capitalized, amortization method | straight-line basis | ||||
Contract costs capitalized, amortization expense | $ 2.7 | $ 2.2 | $ 5.2 | $ 4.3 |
Revenues (Narratives) (Details
Revenues (Narratives) (Details 1) | 6 Months Ended |
Dec. 31, 2023 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Percentage of remaining performance obligations expected to recognize, period | 6 months |
Percentage of remaining performance obligations expected to recognize | 32% |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-07-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Percentage of remaining performance obligations expected to recognize, period | 1 year |
Percentage of remaining performance obligations expected to recognize | 34% |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-07-01 | |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] | |
Percentage of remaining performance obligations expected to recognize, period | |
Percentage of remaining performance obligations expected to recognize, description | thereafter |
Percentage of remaining performance obligations expected to recognize | 34% |
Revenues (Schedule of Revenues
Revenues (Schedule of Revenues Disaggregated by Sales Channel and Geographic Region) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | $ 296,377 | $ 318,348 | $ 649,514 | $ 616,037 |
Distributor | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 162,540 | 186,320 | 385,294 | 353,953 |
Direct | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 133,837 | 132,028 | 264,220 | 262,084 |
United States | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 149,549 | 137,593 | 332,301 | 275,219 |
United States | Distributor | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 81,350 | 70,963 | 199,151 | 144,277 |
United States | Direct | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 68,199 | 66,630 | 133,150 | 130,942 |
Other Americas | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 13,086 | 15,421 | 25,983 | 35,544 |
Other Americas | Distributor | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 8,244 | 10,807 | 10,775 | 26,832 |
Other Americas | Direct | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 4,842 | 4,614 | 15,208 | 8,712 |
Total Americas | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 162,635 | 153,014 | 358,284 | 310,763 |
Total Americas | Distributor | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 89,594 | 81,770 | 209,926 | 171,109 |
Total Americas | Direct | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 73,041 | 71,244 | 148,358 | 139,654 |
EMEA | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 110,605 | 138,050 | 254,208 | 253,559 |
EMEA | Distributor | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 64,082 | 97,147 | 166,393 | 173,403 |
EMEA | Direct | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 46,523 | 40,903 | 87,815 | 80,156 |
APAC | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 23,137 | 27,284 | 37,022 | 51,715 |
APAC | Distributor | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | 8,864 | 7,403 | 8,975 | 9,441 |
APAC | Direct | ||||
Disaggregation Of Revenue [Line Items] | ||||
Net Revenues | $ 14,273 | $ 19,881 | $ 28,047 | $ 42,274 |
Revenues (Schedule of Customers
Revenues (Schedule of Customers Accounting for 10% or More of Net Revenues and Accounts Receivable Balance) (Details) - Customer Concentration Risk | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2023 | |
Westcon Group Inc. | Revenue | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 10% | 19% | 18% | 17% | |
TD Synnex Corporation | Revenue | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 24% | 17% | 21% | 18% | |
TD Synnex Corporation | Accounts Receivable | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 10% | ||||
Jenne, Inc. | Revenue | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 23% | 13% | 25% | 13% | |
Jenne, Inc. | Accounts Receivable | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 52% | 39% | |||
ScanSource, Inc. | Revenue | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 11% | ||||
ScanSource, Inc. | Accounts Receivable | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 10% | ||||
Ingram Micro [Member] | Accounts Receivable | |||||
Concentration Risk [Line Items] | |||||
Concentration risk (percent) | 10% |
Business Combination (Narrative
Business Combination (Narratives) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Business Acquisition [Line Items] | ||
Goodwill | $ 395,606 | $ 394,755 |
Balance Sheet Accounts (Summary
Balance Sheet Accounts (Summary of Cash and Cash Equivalents) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Cash | $ 211,526 | $ 227,675 |
Cash equivalents | 9,877 | 7,151 |
Total cash and cash equivalents | $ 221,403 | $ 234,826 |
Balance Sheet Accounts (Compone
Balance Sheet Accounts (Components of Inventories) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Finished goods | $ 124,668 | $ 78,180 |
Raw materials | 27,853 | 10,844 |
Total inventories | $ 152,521 | $ 89,024 |
Balance Sheet Accounts (Compo_2
Balance Sheet Accounts (Components of Property and Equipment) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 198,576 | $ 190,898 |
Less: accumulated depreciation and amortization | (150,978) | (144,450) |
Property and equipment, net | 47,598 | 46,448 |
Computers and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 83,633 | 81,612 |
Purchased software | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 54,378 | 51,444 |
Office equipment, furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 9,002 | 8,899 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 51,563 | $ 48,943 |
Balance Sheet Accounts (Narrati
Balance Sheet Accounts (Narratives) (Details) | 6 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Standard hardware warranty period (in months) | 1 year |
Standard software warranty period (in days) | 90 days |
Maximum investment in one obligor or maker (percent) | 10% |
Balance Sheet Accounts (Summa_2
Balance Sheet Accounts (Summary of Product Warranty Liability Activity) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Movement in Standard Product Warranty Accrual [Roll Forward] | ||||
Balance beginning of period | $ 12,164 | $ 11,522 | $ 12,322 | $ 10,852 |
New warranties issued | 2,777 | 3,807 | 6,451 | 7,815 |
Warranty expenditures | (3,544) | (3,509) | (7,376) | (6,847) |
Balance end of period | $ 11,397 | $ 11,820 | $ 11,397 | $ 11,820 |
Fair Value Measurements (Schedu
Fair Value Measurements (Schedule of Fair Value for Financial Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Assets | ||
Certificate of deposits | $ 9,877 | $ 7,151 |
Foreign currency derivatives | 133 | 31 |
Total assets measured at fair value | 10,010 | 7,182 |
Level 2 | ||
Assets | ||
Certificate of deposits | 9,877 | 7,151 |
Foreign currency derivatives | 133 | 31 |
Total assets measured at fair value | $ 10,010 | $ 7,182 |
Fair Value Measurements (Narrat
Fair Value Measurements (Narratives) (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2023 | |
Not Designated as Hedging Instrument | Forward Foreign Currency Contracts | |||||
Assets/Liabilities | |||||
Notional principal amount of forward foreign exchange contracts | $ 15,600,000 | $ 15,600,000 | $ 3,400,000 | ||
Maximum maturities for contracts | 40 days | 40 days | |||
Gains (losses) on foreign currency derivative instruments | 400,000 | $ 100,000 | $ 300,000 | $ (400,000) | |
Designated as Hedging Instrument | Forward Foreign Currency Contracts | |||||
Assets/Liabilities | |||||
Unrealized gain (loss) on derivatives | 0 | $ 0 | |||
Level 2 Assets and Liabilities | |||||
Assets/Liabilities | |||||
Long-term debt, fair value | 195,000,000 | 195,000,000 | 225,000,000 | ||
Transfers of assets between Level 1 and Level 2 | 0 | 0 | 0 | 0 | |
Transfers of liabilities between Level 1 and Level 2 | 0 | 0 | 0 | 0 | |
Level 3 Assets and Liabilities | |||||
Assets/Liabilities | |||||
Fair value, measurement level 3 assets, transfers | 0 | 0 | |||
Fair value, measurement level 3 liabilities transfers | 0 | 0 | |||
Transfers of assets between Level 2 and Level 3 | 0 | 0 | 0 | 0 | |
Transfers of liabilities between Level 2 and Level 3 | 0 | 0 | 0 | 0 | |
Fair value assets impairment | 0 | $ 0 | 0 | $ 0 | |
Recurring | |||||
Assets/Liabilities | |||||
Certificate of deposits | 9,877,000 | 9,877,000 | 7,151,000 | ||
Recurring | Level 2 Assets and Liabilities | |||||
Assets/Liabilities | |||||
Certificate of deposits | $ 9,877,000 | $ 9,877,000 | $ 7,151,000 |
Intangible Assets and Goodwil_2
Intangible Assets and Goodwill (Components of Gross and Net Intangible Asset Balances) (Details) - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended |
Dec. 31, 2023 | Jun. 30, 2023 | |
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 247,512 | $ 247,444 |
Accumulated Amortization | 234,408 | 231,381 |
Net Carrying Amount | $ 13,104 | $ 16,063 |
Developed Technology | ||
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | ||
Weighted Average Remaining Amortization Period | 4 years 1 month 6 days | 4 years 1 month 6 days |
Gross Carrying Amount | $ 169,646 | $ 169,460 |
Accumulated Amortization | 161,690 | 159,592 |
Net Carrying Amount | $ 7,956 | $ 9,868 |
Customer Relationships | ||
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | ||
Weighted Average Remaining Amortization Period | 2 years 10 months 24 days | 3 years 4 months 24 days |
Gross Carrying Amount | $ 64,721 | $ 64,839 |
Accumulated Amortization | 59,787 | 58,894 |
Net Carrying Amount | $ 4,934 | $ 5,945 |
Trade Names | ||
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | ||
Weighted Average Remaining Amortization Period | 0 years | 0 years |
Gross Carrying Amount | $ 10,700 | $ 10,700 |
Accumulated Amortization | $ 10,700 | $ 10,700 |
License Agreements | ||
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | ||
Weighted Average Remaining Amortization Period | 2 years 10 months 24 days | 3 years 4 months 24 days |
Gross Carrying Amount | $ 2,445 | $ 2,445 |
Accumulated Amortization | 2,231 | 2,195 |
Net Carrying Amount | $ 214 | $ 250 |
Intangible Assets and Goodwil_3
Intangible Assets and Goodwill (Summary of Amortization Expense of Intangibles) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization of intangibles in “Total cost of revenues” | $ 611 | $ 3,220 | $ 2,044 | $ 6,825 |
Type Of Cost Good Or Service Extensible List | Product | Product | Product | Product |
Amortization of intangibles in “Total operating expenses” | $ 509 | $ 504 | $ 1,020 | $ 1,027 |
Total amortization expense | $ 1,120 | $ 3,724 | $ 3,064 | $ 7,852 |
Intangible Assets and Goodwil_4
Intangible Assets and Goodwill (Schedule Future Amortization for Finite-Lived Intangible Assets) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
For the fiscal year ending: | ||
2024 (the remainder of fiscal 2024) | $ 2,585 | |
2025 | 4,414 | |
2026 | 3,165 | |
2027 | 1,418 | |
2028 | 1,259 | |
Thereafter | 263 | |
Net Carrying Amount | $ 13,104 | $ 16,063 |
Intangible Assets and Goodwil_5
Intangible Assets and Goodwill (Narratives) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Goodwill | $ 395,606 | $ 394,755 |
Debt (Components of Debt) (Deta
Debt (Components of Debt) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Line Of Credit Facility [Line Items] | ||
Less: unamortized debt issuance costs | $ (675) | $ (674) |
Current portion of long-term debt | 9,325 | 34,326 |
Less: unamortized debt issuance costs | (2,069) | (2,409) |
Long-term debt, less current portion | 182,931 | 187,591 |
Total debt | 192,256 | 221,917 |
Term Loan | ||
Line Of Credit Facility [Line Items] | ||
Current portion of long-term debt | 10,000 | 10,000 |
Long-term debt, less current portion | $ 185,000 | 190,000 |
Revolving Facility | ||
Line Of Credit Facility [Line Items] | ||
Current portion of long-term debt | $ 25,000 |
Debt (Narratives) (Details)
Debt (Narratives) (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Jul. 07, 2023 | Jun. 22, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Line Of Credit Facility [Line Items] | ||||||
Payments of lines of credit | $ 25,000,000 | |||||
Outstanding letters of credit | $ 14,500,000 | 14,500,000 | ||||
Interest Expense | ||||||
Line Of Credit Facility [Line Items] | ||||||
Amortization of deferred financing costs | 300,000 | $ 700,000 | $ 500,000 | $ 1,500,000 | ||
2019 Credit Agreement | ||||||
Line Of Credit Facility [Line Items] | ||||||
Debt instrument interest rate | 5.50% | |||||
2019 Credit Agreement | Term Loan | ||||||
Line Of Credit Facility [Line Items] | ||||||
Payments of lines of credit | $ 30,000,000 | |||||
2023 Credit Agreement | ||||||
Line Of Credit Facility [Line Items] | ||||||
Debt instrument interest rate | 7.46% | |||||
2023 Credit Agreement | Term Loan | ||||||
Line Of Credit Facility [Line Items] | ||||||
Payments of lines of credit | $ 0 | |||||
2023 Credit Agreement | Revolving Facility | ||||||
Line Of Credit Facility [Line Items] | ||||||
Borrowing capacity from Credit Agreement | $ 150,000,000 | |||||
Amount borrowed under Term Loan | $ 25,000,000 | |||||
Payments of lines of credit | $ 25,000,000 | |||||
Line of credit facility remaining outstanding balance | 0 | 0 | ||||
Borrowing capacity from Credit Agreement | $ 135,500,000 | $ 135,500,000 | ||||
Credit Agreement | Applicable Margin for SOFR | ||||||
Line Of Credit Facility [Line Items] | ||||||
Debt instrument, subject to floor | 0% | |||||
Debt instrument, spread adjustment | 0.10% | |||||
Credit Agreement | Term Loan | ||||||
Line Of Credit Facility [Line Items] | ||||||
Borrowing capacity from Credit Agreement | $ 200,000,000 | |||||
Credit Agreement | Revolving Facility | ||||||
Line Of Credit Facility [Line Items] | ||||||
Credit Facility, term | 5 years | |||||
Borrowing capacity from Credit Agreement | $ 150,000,000 | |||||
Maximum | Credit Agreement | ||||||
Line Of Credit Facility [Line Items] | ||||||
Additional incremental loan facility | $ 100,000,000 | |||||
Maximum | Credit Agreement | Applicable Margin for Base Rate | ||||||
Line Of Credit Facility [Line Items] | ||||||
Borrowings, interest rate | 1.75% | |||||
Maximum | Credit Agreement | Applicable Margin for SOFR | ||||||
Line Of Credit Facility [Line Items] | ||||||
Borrowings, interest rate | 2.75% | |||||
Minimum | Credit Agreement | Applicable Margin for Base Rate | ||||||
Line Of Credit Facility [Line Items] | ||||||
Borrowings, interest rate | 1% | |||||
Minimum | Credit Agreement | Applicable Margin for SOFR | ||||||
Line Of Credit Facility [Line Items] | ||||||
Borrowings, interest rate | 2% |
Commitments and Contingencies (
Commitments and Contingencies (Narratives) (Details) | Dec. 31, 2023 USD ($) |
Non-Cancelable Inventory | |
Commitments And Contingencies [Line Items] | |
Non-cancelable purchase commitments | $ 92,100,000 |
Stockholders' Equity (Narrative
Stockholders' Equity (Narratives) (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||||
Sep. 14, 2023 | May 18, 2022 | Sep. 09, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Nov. 17, 2022 | |
Class Of Stock [Line Items] | ||||||||
Total number of shares repurchased | 1,485,005 | 2,578,175 | 2,365,220 | 2,578,175 | ||||
Stock repurchased during period, value | $ 25,000,000 | $ 49,800,000 | $ 49,900,000 | $ 49,800,000 | ||||
Stock repurchase, extended period, effective date | Jul. 01, 2022 | |||||||
Share repurchased outstanding amount | $ 50,300,000 | $ 50,300,000 | ||||||
Excise tax on stock repurchases | 1% | 1% | ||||||
2022 Repurchase Program | ||||||||
Class Of Stock [Line Items] | ||||||||
Stock repurchase, extended period | 3 years | |||||||
Stock repurchased average price per share | $ 16.81 | $ 19.32 | $ 21.08 | $ 19.32 | ||||
2022 Repurchase Program | Maximum | ||||||||
Class Of Stock [Line Items] | ||||||||
Stock repurchase, authorized amount | $ 200,000,000 | $ 50,000,000 | ||||||
Maximum amount of common stock may be repurchased in any quarter | $ 25,000,000 | |||||||
Stock repurchase, increase in authorized amount | $ 25,000,000 | |||||||
2013 Equity Incentive Plan | ||||||||
Class Of Stock [Line Items] | ||||||||
Maximum number of shares available for sale under equity incentive plan | 5,000,000 | |||||||
2014 Employee Stock Purchase Plan | ||||||||
Class Of Stock [Line Items] | ||||||||
Maximum number of shares available for sale under equity incentive plan | 7,500,000 |
Employee Benefit Plans (Shares
Employee Benefit Plans (Shares Reserved for Issuance) (Details) - shares shares in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Class Of Stock [Line Items] | ||
Shares reserved for issuance | 29,457 | 28,500 |
2014 Employee Stock Purchase Plan | ||
Class Of Stock [Line Items] | ||
Shares reserved for issuance | 7,948 | 8,467 |
Employee Stock Options and Awards Outstanding | ||
Class Of Stock [Line Items] | ||
Shares reserved for issuance | 8,875 | 10,038 |
2013 Equity Incentive Plan Shares Available for Grant | ||
Class Of Stock [Line Items] | ||
Shares reserved for issuance | 12,634 | 9,995 |
Employee Benefit Plans (Schedul
Employee Benefit Plans (Schedule of Recognized Share-based Compensation Expense) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] | ||||
Share-based compensation expense | $ 20,957 | $ 17,396 | $ 40,876 | $ 31,185 |
Cost of Product Revenue | ||||
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] | ||||
Share-based compensation expense | 464 | 499 | 947 | 873 |
Cost of Subscription And Support Revenues | ||||
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] | ||||
Share-based compensation expense | 749 | 966 | 1,615 | 1,638 |
Research and Development | ||||
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] | ||||
Share-based compensation expense | 4,435 | 3,962 | 8,812 | 7,052 |
Sales and Marketing | ||||
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] | ||||
Share-based compensation expense | 7,535 | 5,910 | 14,523 | 10,549 |
General and Administrative | ||||
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] | ||||
Share-based compensation expense | $ 7,774 | $ 6,059 | $ 14,979 | $ 11,073 |
Employee Benefit Plans (Summary
Employee Benefit Plans (Summary of Stock Option Activity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 6 Months Ended | 12 Months Ended |
Dec. 31, 2023 | Jun. 30, 2023 | |
Number of Shares | ||
Options outstanding at June 30, 2023 | 1,187 | |
Exercised | (57) | |
Options outstanding at September 30, 2023 | 1,130 | 1,187 |
Vested and expected to vest at September 30, 2023 | 1,130 | |
Exercisable at September 30, 2023 | 1,130 | |
Weighted-Average Exercise Price Per Share | ||
Options outstanding at June 30, 2023 | $ 6.56 | |
Exercised | 6.40 | |
Options outstanding at September 30, 2023 | 6.57 | $ 6.56 |
Vested and expected to vest at September 30, 2023 | 6.57 | |
Exercisable at September 30, 2023 | $ 6.57 | |
Weighted-Average Remaining Contractual Term | ||
Options outstanding | 2 years 2 months 19 days | 2 years 8 months 12 days |
Vested and expected to vest at September 30, 2023 | 2 years 2 months 19 days | |
Exercisable at September 30, 2023 | 2 years 2 months 19 days | |
Aggregate Intrinsic Value | ||
Options outstanding | $ 12,513 | $ 23,136 |
Vested and expected to vest at September 30, 2023 | 12,513 | |
Exercisable at September 30, 2023 | $ 12,513 |
Employee Benefit Plans (Narrati
Employee Benefit Plans (Narratives) (Details) - $ / shares | 6 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Awards exercised | 57,000 | |
Granted | 3,553,000 | |
Granted | $ 29.3 | |
Stock price target | 46.96 | |
Initial Performance Period | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Stock price target | $ 41.38 | |
3rd Anniversary | Initial Performance Period | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Vesting Rights Percentage | 50% | |
4th Anniversary | Initial Performance Period | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Vesting Rights Percentage | 50% | |
Restricted Stock Units (RSUs) | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Share-based compensation arrangement by share-based payment award, award vesting percentage | The RSUs granted under the 2013 Plan vest over a period of time, generally one to three years, and are subject to participant's continued service to the Company. | |
MSU | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Calculation of total shareholder return (TSR), description | Total shareholder return is calculated based on the average closing price for the 30-trading days prior to the beginning and end of the performance periods. Performance is measured based on three periods, with the ability for up to one-third of target shares to vest after years one and two and the ability for up to the maximum of the full award to vest based on the full three-year TSR less any shares vested based on one- and two-year periods. | |
MSU Subject to Total Shareholder Return (TSR) | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Granted | $ 34.09 | $ 16.57 |
Volatility | 50% | 67% |
Risk-free interest rate | 4.48% | 3.12% |
Dividend yield | 0% | 0% |
Expected term | 3 years | 3 years |
MSU Subject to Stock Price Targets | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Granted | $ 28.80 | |
Volatility | 63% | |
Risk-free interest rate | 4.45% | |
Dividend yield | 0% | |
Executive Officers and Directors | Restricted Stock Units (RSUs) | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Granted | 600,000 | |
Executive Officer Member | Restricted Stock Units (RSUs) | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Granted | 800,000 | 1,000,000 |
Executive Officer Member | MSU | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Shares vested, Maximum | 150% | |
Executive Officer Member | MSU Subject to Total Shareholder Return (TSR) | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Granted | 500,000 | |
Executive Officer Member | MSU Subject to Stock Price Targets | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Granted | 300,000 | |
2013 Equity Incentive Plan | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Granted | 0 | 0 |
2014 Employee Stock Purchase Plan | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Shares issued under stock purchase plan | 500,000 | 700,000 |
Weighted-average grant-date fair value of options issued (in dollars per share) | $ 8.09 | $ 4.38 |
Employee Benefit Plans (Summa_2
Employee Benefit Plans (Summary of Stock Award Activity) (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 6 Months Ended |
Dec. 31, 2023 USD ($) $ / shares shares | |
Number of Shares | |
Non-vested stock awards outstanding at June 30, 2023 | shares | 8,851 |
Granted | shares | 3,553 |
Released | shares | (4,114) |
Canceled | shares | (545) |
Non-vested stock awards outstanding at September 30, 2023 | shares | 7,745 |
Stock awards expected to vest at September 30, 2023 | shares | 7,745 |
Weighted-Average Grant Date Fair Value | |
Non-vested stock awards outstanding at June 30, 2023 | $ / shares | $ 14.25 |
Granted | $ / shares | 29.3 |
Released | $ / shares | 12.57 |
Canceled | $ / shares | 17.51 |
Non-vested stock awards outstanding at September 30, 2023 | $ / shares | 21.81 |
Stock awards expected to vest at September 30, 2023 | $ / shares | $ 21.81 |
Aggregate Fair Market Value | |
Non-vested stock awards outstanding at September 30, 2023 | $ | $ 168,918 |
Stock awards expected to vest at September 30, 2023 | $ | $ 168,918 |
Employee Benefit Plans (Sched_2
Employee Benefit Plans (Schedule of PSUs Earned and Vested Based on Total Stockholder Return (TSR PSUs)) (Details) - Executive Officer Member - TSR PSU | 6 Months Ended |
Dec. 31, 2023 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Relative TSR, Below Threshold | TSR is less than the Index by more than 37.5 percentage points |
Relative TSR, Threshold | TSR is less than the Index by 37.5 percentage points |
Relative TSR, Target | TSR equals the Index |
Relative TSR, Maximum | TSR is greater than the Index by 25 percentage points or more |
Shares vested, Below Threshold | 0% |
Shares vested, Threshold | 25% |
Shares vested, Target | 100% |
Shares vested, Maximum | 150% |
Employee Benefit Plans (Sched_3
Employee Benefit Plans (Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards) (Details) - Employee Stock Purchase Plan | 6 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ||
Expected term | 6 months | 6 months |
Risk-free interest rate | 5.54% | 3.12% |
Volatility | 42% | 60% |
Dividend yield | 0% | 0% |
Information about Segments an_3
Information about Segments and Geographic Areas (Narratives) (Details) | 6 Months Ended |
Dec. 31, 2023 Geographic_Area Segment | |
Segment Reporting [Abstract] | |
Number of operating segments | Segment | 1 |
Number of geographic regions | Geographic_Area | 3 |
Information about Segments an_4
Information about Segments and Geographic Areas (Schedule of Long Lived Assets by Segment) (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | $ 188,809 | $ 170,794 |
Americas | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | 140,161 | 124,375 |
EMEA | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | 37,335 | 35,175 |
APAC | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | $ 11,313 | $ 11,244 |
Derivatives and Hedging (Narrat
Derivatives and Hedging (Narratives) (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Derivative [Line Items] | ||||
Foreign currency transactions realized gains (losses) | $ (700,000) | $ 100,000 | $ (300,000) | $ 800,000 |
Interest Rate Swap | ||||
Derivative [Line Items] | ||||
Notional principal amount of forward foreign exchange contracts | 75,000,000 | $ 75,000,000 | ||
Maturity date | Apr. 30, 2023 | |||
Derivative outstanding amount | 0 | 0 | ||
Unrealized gain (loss) on interest rate cash flow hedges | $ 800,000 | |||
Forward Foreign Currency Contracts | Not Designated as Hedging Instrument | ||||
Derivative [Line Items] | ||||
Notional principal amount of forward foreign exchange contracts | 15,600,000 | 11,100,000 | $ 15,600,000 | 11,100,000 |
Maximum maturities for contracts | 40 days | |||
Net gains (losses) on forward foreign currency contracts | $ 400,000 | $ 100,000 | $ 300,000 | $ (400,000) |
Restructuring and Related Cha_2
Restructuring and Related Charges (Narratives) (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Restructuring Cost And Reserve [Line Items] | ||||
Restructuring charges, net of reversals and impairment | $ 9.2 | $ 0.5 | $ 11.9 | $ 1 |
2023 Plan | ||||
Restructuring Cost And Reserve [Line Items] | ||||
Expected restructuring charges | 10 | 10 | ||
2023 Plan | Move Cost | ||||
Restructuring Cost And Reserve [Line Items] | ||||
Restructuring charges | $ 0.2 | 0.2 | ||
2023 Plan | Maximum | ||||
Restructuring Cost And Reserve [Line Items] | ||||
Restructuring project completion, Duration | 12 months | |||
2023 Plan | Minimum | ||||
Restructuring Cost And Reserve [Line Items] | ||||
Restructuring project completion, Duration | 9 months | |||
Q2 2024 Plan | ||||
Restructuring Cost And Reserve [Line Items] | ||||
Restructuring charges | $ 8.8 | |||
Expected restructuring charges | 4.5 | 4.5 | ||
Restructuring liabilities | 6.2 | 6.2 | ||
Q1 2024 Plan | ||||
Restructuring Cost And Reserve [Line Items] | ||||
Restructuring charges, net of reversals and impairment | $ 0.2 | $ 2.9 |
Income Taxes (Narratives) (Deta
Income Taxes (Narratives) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Income tax provision (benefit) | $ 3,069 | $ 2,646 | $ 7,632 | $ 4,394 |
US Federal income tax | 200 | 1,600 | ||
Unrecognized tax benefits | 18,300 | 18,300 | ||
Unrecognized tax benefits that would affect the effective tax rate if recognized | 200 | 200 | ||
Unrecognized tax benefit future impact if recognized | $ 18,100 | $ 18,100 |
Net Income Per Share (Schedule
Net Income Per Share (Schedule of Earnings Per Share, Basic and Diluted) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Earnings Per Share Diluted [Line Items] | ||||
Net income | $ 3,988 | $ 17,931 | $ 32,664 | $ 30,516 |
Weighted-average shares used in per share calculation – basic | 128,987 | 130,465 | 128,885 | 130,377 |
Weighted-average shares used in per share calculation – diluted | 131,514 | 134,453 | 132,786 | 133,833 |
Net income per share - basic | ||||
Net income per share – basic | $ 0.03 | $ 0.14 | $ 0.25 | $ 0.23 |
Net income per share - diluted | ||||
Net income per share – diluted | $ 0.03 | $ 0.13 | $ 0.25 | $ 0.23 |
Options to purchase common stock | ||||
Earnings Per Share Diluted [Line Items] | ||||
Options to purchase common stock | 757 | 717 | 836 | 635 |
Restricted stock units | ||||
Earnings Per Share Diluted [Line Items] | ||||
Options to purchase common stock | 1,579 | 3,164 | 2,951 | 2,760 |
Employee Stock Purchase Plan shares | ||||
Earnings Per Share Diluted [Line Items] | ||||
Options to purchase common stock | 191 | 107 | 114 | 61 |
Net Income Per Share (Schedul_2
Net Income Per Share (Schedule of Anti-Dilutive Shares Excluded from Earnings Per Share Calculation) (Details) - shares shares in Thousands | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of EPS | 2,896 | 1,115 | 2,068 | 835 |
Restricted stock units | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of EPS | 2,336 | 437 | 1,623 | 306 |
Employee Stock Purchase Plan shares | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of EPS | 560 | 678 | 445 | 529 |